Archived Publications

2020

RII authors are marked with an asterisk(*).

  1. 5-(Perylen-3-ylethynyl)uracil Derivatives Inhibit Reproduction of Respiratory Viruses
    Nikolayeva* Y V, Ulashchik E A, Chekerda* E V, Galochkina* A V, Slesarchuk N A, Chistov A A, Nikitin T D, Korshun V A, Shmanai V V, Ustinov A V, Shtro* A A
    Russian Journal of Bioorganic Chemistry — 2020. — Vol. 46. — Issue. 3. — pp. 315-320
    DOI: 10.1134/S1068162020030139
  2. A highly efficient and safe gene delivery platform based on polyelectrolyte core-shell nanoparticles for hard-to-transfect clinically relevant cell types
    Tarakanchikova Yana, Muslimov Albert, Sergeev Igor, Lepik Kirill, Yolshin* Nikita, Goncharenko Alexander, Vasilyev* Kirill, Eliseev Igor, Bukatin Anton, Sergeev Vladislav, Pavlov Sergey, Popov Alexey, Meglinski Igor, Afanasiev Boris, Parakhonskiy Bogdan, Sukhorukov Gleb, Gorin Dmitry
    Journal of Materials Chemistry B — 2020. — Vol. 8. — Issue. 41. — pp. 9576-9588
    DOI: 10.1039/d0tb01359e
  3. A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults
    Kiseleva Irina, Isakova-Sivak Irina, Stukova* Marina, Erofeeva* Marianna, Donina Svetlana, Larionova Natalie, Krutikova Elena, Bazhenova Ekaterina, Stepanova* Ekaterina, Vasilyev* Kirill, Matyushenko Victoria, Krylova Marina, Galatonova Julia, Ershov Aleksey, Lioznov* Dmitry, Sparrow Erin Grace, Torelli Guido, Rudenko Larisa
    Vaccines — 2020. — Vol. 8. — Issue. 2. — pp. -
    DOI: 10.3390/vaccines8020296
  4. A plant-based transient expression system for the rapid production of highly immunogenic Hepatitis E virus-like particles
    Mardanova Eugenia S, Takova Katerina H, Toneva Valentina T, Zahmanova Gergana G, Tsybalova* Liudmila M, Ravin Nikolai V
    Biotechnology Letters — 2020. — Vol. 42. — Issue. 11. — pp. 2441-2446
    DOI: 10.1007/s10529-020-02995-x
  5. Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010‐2018
    Mook Piers, Meerhoff Tamara, Olsen Sonja J, Snacken Rene, Adlhoch Cornelia, Pereyaslov Dmitriy, Broberg Eeva K, Melidou Angeliki, Brown Caroline, Penttinen Pasi, Collective of the WHO European Region European Influenza Surveillance Network (…, Sominina* Anna A.,...)
    Influenza and Other Respiratory Viruses — 2020. — Vol. 14. — Issue. 2. — pp. 150-161
    DOI: 10.1111/irv.12703
  6. Antibody microarray immunoassay for screening and differential diagnosis of upper respiratory tract viral pathogens
    Plotnikova* Marina A., Klotchenko* Sergey A., Lebedev* Kirill, I, Lozhkov* Alexey A., Taraskin* Aleksandr S., Gyulikhandanova* Natalia E., Ramsay* Edward S., Vasin* Andrey V.
    Journal of Immunological Methods — 2020. — Vol. 478. — Issue. . — pp. -112712
    DOI: 10.1016/j.jim.2019.112712
  7. Antiviral activity of amides and carboxamides of quinolizidine alkaloid (-)-cytisine against human influenza virus A (H1N1) and parainfluenza virus type 3
    Fedorova* Victoria A., Kadyrova* Renata A., Slita Alexander V, Muryleva Anna A., Petrova Polina R., Kovalskaya Alena V, Lobov Alexander N., Zileeva Zulfiya R., Tsypyshev Dmiry O., Borisevich Sophia S., Tsypysheva Inna P., Vakhitova Julia V., Zarubaev Vladimir V.
    Natural Product Research — 2020. — Vol. . — Issue. . — pp. 1-9
    DOI: 10.1080/14786419.2019.1696791
  8. Cold and distant: structural features of the nucleoprotein complex of a cold-adapted influenza A virus strain
    Shvetsov A V, Lebedev D V, Zabrodskaya* Y A, Shaldzhyan* A A, Egorova* M A, Vinogradova D S, Konevega A L, Gorshkov* A N, Ramsay* E S, Radulescu A, Sergeeva* M V, Plotnikova* M A, Komissarov* A B, Taraskin* A S, Lebedev* K I, Garmay Yu P, Kuznetsov* V V, Isaev-Ivanov V V, Vasin* A V, Tsybalova* L M, Egorov* V V
    Journal of Biomolecular Structure & Dynamics — 2020. — Vol. . — Issue. . — pp. 1-10
    DOI: 10.1080/07391102.2020.1776636
  9. Complicated hospitalization due to influenza: results from the Global Hospital Influenza Networkfor the 2017-2018 season
    Lina Bruno, Georges Alexandre, Burtseva Elena, Nunes Marta C, Andrew Melissa K, McNeil Shelly A, Ruiz-Palacios Guillermo M, Feng Luzhao, Kyncl Jan, Vanhems Philippe, Ortiz Justin R, Paget John, Reiner Robert C, on behalf of the GIHSN 2017–2018 study collaborators (..., Sominina* Anna,...)
    BMC Infectious Diseases — 2020. — Vol. 20. — Issue. 1. — pp. 465-
    DOI: 10.1186/s12879-020-05167-4
  10. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses
    Matyushenko Victoria, Kotomina Tatiana, Kudryavtsev Igor, Mezhenskaya Daria, Prokopenko Polina, Matushkina Anastasia, Sivak* Konstantin, Muzhikyan* Arman, Rudenko Larisa, Isakova-Sivak Irina
    Antiviral Research — 2020. — Vol. 182. — Issue. . — pp. 104864-
    DOI: 10.1016/j.antiviral.2020.104864
  11. Design of a randomized controlled trial to Link Infectious and Narcology Care (LINC-II) in St. Petersburg, Russia
    Gnatienko Natalia, Lioznov* Dmitry, Raj Anita, Blokhina Elena, Rosen Sydney, Cheng Debbie M., Lunze Karsten, Bendiks Sally, Truong Ve, Bushara Natalia, Toussova Olga, Quinn Emily, Krupitsky Evgeny, Samet Jeffrey H.
    Addiction Science & Clinical Practice — 2020. — Vol. 15. — Issue. 1. — pp. -1
    DOI: 10.1186/s13722-020-0179-8
  12. Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial
    Freiberg Matthew S, Cheng Debbie M, Gnatienko Natalia, Blokhina Elena, Coleman Sharon M, Doyle Margaret F, Yaroslavtseva Tatiana, Bridden Carly, So-Armah Kaku, Tracy Russell, Bryant Kendall, Lioznov* Dmitry, Krupitsky Evgeny, Samet Jeffrey H
    JAMA Network Open — 2020. — Vol. 3. — Issue. 5. — pp. e204330-
    DOI: 10.1001/jamanetworkopen.2020.4330
  13. Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis
    Nurbubu T. Moldogazieva, Daria S. Ostroverkhova, Nikolai N. Kuzmich*, Vladimir V. Kadochnikov, Alexander A. Terentiev and Yuri B. Porozov
    International Journal of Molecular Sciences. — 2020. — Vol. 21. — Issue. 3. — pp. 893-
    DOI: 10.3390/ijms21030893
  14. Experimental Infection Using Mouse-Adapted Influenza B Virus in a Mouse Model
    Prokopyeva Elena, Kurskaya Olga, Sobolev Ivan, Solomatina Mariia, Murashkina Tatyana, Suvorova Anastasia, Alekseev Alexander, Danilenko* Daria, Komissarov* Andrey, Fadeev* Artem, Ramsay* Edward, Shestopalov Alexander, Dygai Alexander, Sharshov Kirill
    Viruses — 2020. — Vol. 12. — Issue. 4. — pp. -
    DOI: 10.3390/v12040470
  15. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
    Alm Erik, Broberg Eeva K, Connor Thomas, Hodcroft Emma B, Komissarov* Andrey B, Maurer-Stroh Sebastian, Melidou Angeliki, Neher Richard A, O'Toole Aine, Pereyaslov Dmitriy
    Euro Surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin — 2020. — Vol. 25. — Issue. 32. — pp. -
    DOI: 10.2807/1560-7917.ES.2020.25.32.2001410
  16. Human respiratory syncytial virus and influenza seasonality patterns—Early findings from the WHO global respiratory syncytial virus surveillance
    Mandeep Chadha, Siddhivinayak Hirve, Christina Bancej, Ian Barr, Elsa Baumeister, Braulia Caetano, Malinee Chittaganpitch, Badarch Darmaa, Joanna Ellis, Rodrigo Fasce, Herve Kadjo, Sandra Jackson, Vivian Leung, Maria Pisareva*, Jocelyn Moyes, Amel Naguib, Almiro Tivane, Wenqing Zhang, On behalf of the WHO RSV Surveillance Group (..., Elizaveta Smorodintseva*,...)
    Influenza and Other Respiratory Viruses — 2020. — Vol. 14. — Issue. 6. — pp. 638-646
    DOI: 10.1111/irv.12726
  17. Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption-an observational cross-sectional study
    So-Armah Kaku, Freiberg Matthew, Cheng Debbie, Lim Joseph K., Gnatienko Natalia, Patts Gregory, Doyle Margaret, Fuster Daniel, Lioznov* Dmitry, Krupitsky Evgeny, Samet Jeffrey
    BMC Gastroenterology — 2020. — Vol. 20. — Issue. 1. — pp. -1
    DOI: 10.1186/s12876-019-1136-4
  18. Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP preparation in limiting postinfluenza Staphylococcus aureus infections
    Klausberger Miriam, Leneva Irina A., Egorov* Andrey, Strobl Florian, Ghorbanpour Sahar M., Falynskova Irina N., Poddubikov Alexander, V, Makhmudova Nailya R., Krokhin Artem, Svitich Oxana A., Grabherr Reingard
    Vaccine — 2020. — Vol. 38. — Issue. 4. — pp. 859-867
    DOI: 10.1016/j.vaccine.2019.10.083
  19. Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin
    Elena A. Blokhina, Eugenia S. Mardanova, Liudmila A. Stepanova*, Liudmila M. Tsybalova* and Nikolai V. Ravin
    Plants — 2020. — Vol. 9. — Issue. 2. — pp. 162-
    DOI: 10.3390/plants9020162
  20. Presenting a conceptual framework for an HIV prevention and care continuum and assessing the feasibility of empirical measurement in Estonia: A case study
    Uuskula Anneli, Vickerman Peter, Raag Mait, Walker Josephine, Paraskevis Dimitrios, Eritsyan Ksenia, Sypsa Vana, Lioznov* Dmitry, Avi Radko, Des Jarlais Don
    PloS One — 2020. — Vol. 15. — Issue. 10. — pp. e0240224-
    DOI: 10.1371/journal.pone.0240224
  21. Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections
    Isakova-Sivak Irina, Matyushenko Victoria, Stepanova Ekaterina, Matushkina Anastasia, Kotomina Tatiana, Mezhenskaya Daria, Prokopenko Polina, Kudryavtsev Igor, Kopeykin Pavel, Sivak* Konstantin, Rudenko Larisa
    Vaccines — 2020. — Vol. 8. — Issue. 2. — pp. -
    DOI: 10.3390/vaccines8020196
  22. Replicative senescence in MSCWJ-1 human umbilical cord mesenchymal stem cells is marked by characteristic changes in motility, cytoskeletal organization, and RhoA localization
    Bobkov* Danila, Polyanskaya Anastasia, Musorina Anastasia, Lomert Ekaterina, Shabelnikov Sergey, Poljanskaya Galina
    Molecular biology reports — 2020. — Vol. 47. — Issue. 5. — pp. 3867-3883
    DOI: 10.1007/s11033-020-05476-6
  23. Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17
    Jackson Sandra, Peret Teresa C T, Ziegler Thedi T, Thornburg Natalie J, Besselaar Terry, Broor Shobha, Barr Ian, Baumeister Elsa, Chadha Mandeep, Chittaganpitch Malinee, Darmaa Badarch, Ellis Joanna, Fasce Rodrigo, Herring Belinda, Herve Kadjo, Hirve Siddhivinayak, Li Yan, Pisareva* Maria, Moen Ann, Naguib Amel, Palekar Rakhee, Potdar Varsha, Siqueira Marilda, Treurnicht Florette, Tivane Almiro, Venter Marietjie, Wairagkar Niteen, Zambon Maria, Zhang Wenqing
    Influenza and Other Respiratory Viruses — 2020. — Vol. 14. — Issue. 6. — pp. 671-677
    DOI: 10.1111/irv.12771
  24. Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan
    Sarsenbayeva Gulbanu, Issagulov Timur, Kassenov Markhabat, Abitay Ruslan, Orynbayev Mukhit, Stukova* Marina, Pisareva* Maria, Davlyatshin Timur, Kutumbetov Lespek, Khairullin Berik
    Human Vaccines & Immunotherapeutics — 2020. — Vol. 16. — Issue. 8. — pp. 1791-1797
    DOI: 10.1080/21645515.2019.1705691
  25. The Effect of TLR4 Blockade on Some Indicators of Systemic Inflammatory Response to Proteus mirabilis LPS in Rats
    Sivak* K V, Stosman* K I, Rassokha* T A, Aleksandrov* A G, Kuzmich* N N, Orshanskaya* Ya R, Savateeva-Lubimova* T N, Lesiovskaya* E E
    Bulletin of Experimental Biology and Medicine — 2020. — Vol. 169. — Issue. 6. — pp. 795-797
    DOI: 10.1007/s10517-020-04981-9
  26. The Evolution of Pleconaril: Modified O-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy
    Volobueva Alexandrina, Egorova Anna, Galochkina* Anastasia, Ekins Sean, Zarubaev Vladimir, Makarov Vadim
    Molecules — 2020. — Vol. 25. — Issue. 6. — pp. -
    DOI: 10.3390/molecules25061345
  27. Therapeutic efficacy of arginine-rich exenatide on diabetic neuropathy in rats
    Shekunova Elena V., Kashkin Vladimir A., Muzhikyan* Arman A., Makarova Marina N., Balabanyan Vadim Y., Makarov Valery G.
    European Journal of Pharmacology — 2020. — Vol. 866. — Issue. . — pp. -172835
    DOI: 10.1016/j.ejphar.2019.172835
  28. Time machine: Can a dye from 1928 be re-purposed for modern, fluorescence-based detection of amyloid-like fibrils?
    Antimonova O.I, Grudinina N.A., Egorov* V.V., Ilyin V.V., Zabrodskaya* Y.A., Ramsay* E.S., Shabalin K.A., Protasov* A., V, Yakimov A.P., Polukeev V.A., Shavlovsky M.M.
    Dyes and Pigments — 2020. — Vol. 172. — Issue. . — pp. -107863
    DOI: 10.1016/j.dyepig.2019.107863
  29. Ultrastructural Changes in the Air-Blood Barrier of Rats in Acute Intoxication with Furoplast Pyrolysis Products
    Tolkach P G, Basharin V A, Chepur S V, Gorshkov* A N, Sizova D T
    Bulletin of Experimental Biology and Medicine — 2020. — Vol. 169. — Issue. 2. — pp. 270-275
    DOI: 10.1007/s10517-020-04866-x

2019

RII authors are marked with an asterisk(*).

  1. A double-edged sword: supramolecular complexes of triazavirine display multicenter binding effects which influence aggregate formation
    Zabrodskaya* Yana A., Shvetsov Alexey V., Tsvetkov* Vladimir B., Egorov* Vladimir V.
    Journal of Biomolecular Structure & Dynamics — 2019. — Vol. 37. — Issue. 12. — pp. 3041-3047
    DOI: 10.1080/07391102.2018.1507837
  2. A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care
    Samet JH, Blokhina E, Cheng DM, Walley AY, Lioznov* D, Gnatienko N, Quinn EK, Bridden C, Chaisson CE, Toussova O, Gifford AL, Raj A, Krupitsky E.
    AIDS — 2019. — Vol. 33. — Issue. 9. — pp. 1467-1476
    DOI: 10.1097/QAD.0000000000002230
  3. Absolute Quantitation of Proteins by Acid Hydrolysis Combined With Amino Acid Detection by Mass Spectrometry
    Mirgorodskaya* O.A., Körner R., Kozmin Y.P., Roepstorff P.
    Amino Acid Analysis — 2019. — Vol. 2030. — Issue. . — pp. 11-16
    DOI: 10.1007/978-1-4939-9639-1_2
  4. Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies
    Mitrofanova L.B., Vorobeva O.M., Gorshkov* A.N.
    Oncotarget — 2019. — Vol. 10. — Issue. 3. — pp. 289-312
    DOI: 10.18632/oncotarget.26513
  5. Approval of the method of electrophoretic separation and identification of some urine proteins in rats with toxic nephropathy (English abstract only)
    Sivak* K.V., Zabrodskaya* Ya.A., Dobrovolskaya* O.A.
    Medical Academic Journal — 2019. — Vol. . — Issue. . — pp. -
    DOI: 10.17816/MAJ19371-82
  6. Association between alcohol use and inflammatory biomarkers over time among younger adults with HIV-The Russia ARCH Observational Study
    So-Armah KA, Cheng DM, Freiberg MS, Gnatienko N, Patts G, Ma Y, White L, Blokhina E, Lioznov* D, Doyle MF, Tracy RP, Chichetto N, Bridden C, Bryant K, Krupitsky E, Samet JH.
    PLoS One — 2019. — Vol. 14. — Issue. 8. — pp. -
    DOI: 10.1371/journal.pone.0219710
  7. Benzothiazole-based cyanines as fluorescent light-up probes for duplex and quadruplex DNA
    Turaev Anton V., Tsvetkov* Vladimir B., Tankevich Maria V, Smirnov Igor P., Aralov Andrey V, Pozmogova Galina E., Varizhuk Anna M.
    Biochimie — 2019. — Vol. 162. — Issue. . — pp. 216-228
    DOI: 10.1016/j.biochi.2019.04.018
  8. Biological Kerker Effect Boosts Light Collection Efficiency in Plants
    Barhom Hani, Machnev Andrey A., Noskov Roman E., Goncharenko* Alexander, Gurvitz Egor A., Timin Alexander S., Shkoldin Vitaliy A., Koniakhin Sergei V., Koval Olga Yu., Zyuzin Mikhail V., Shalin Alexander S., Shishkin Ivan I., Ginzburg Pavel
    Nano Letters — 2019. — Vol. 19. — Issue. 10. — pp. 7062-7071
    DOI: 10.1021/acs.nanolett.9b02540
  9. Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats
    Fedorova Olga V., Fadeev* Artem V., Grigorova Yulia N., Marshall Courtney A., Zernetkina Valentina, Kolodkin Nikolai I., Agalakova Natalia I., Konradi Alexandra O., Lakatta Edward G., Bagrov Alexei Y.
    Journal of Cardiovascular Pharmacology — 2019. — Vol. 74. — Issue. 5. — pp. 436-442
    DOI: 10.1097/FJC.0000000000000730
  10. Changes in RNA secondary structure affect NS1 protein expression during early stage influenza virus infection
    Baranovskaya* Irina, Sergeeva* Mariia, Fadeev* Artem, Kadirova* Renata, Ivanova* Anna, Ramsay* Edward, Vasin* Andrey
    Virology Journal — 2019. — Vol. 16. — Issue. 1. — pp. -162
    DOI: 10.1186/s12985-019-1271-0
  11. Changing times: Fluorescence-lifetime analysis of amyloidogenic SF-IAPP fusion protein
    Antimonova Olga I., Lebedev Dmitry V., Zabrodskaya* Yana A., Grudinina Natalia A., Timkovsky Andrey L., Ramsay Edward, Shavlovsky Michael M., Egorov* Vladimir V.
    Journal of Structural Biology — 2019. — Vol. 205. — Issue. 1. — pp. 78-83
    DOI: 10.1016/j.jsb.2018.11.006
  12. Clinical characteristics, predictors, and performance of case definition—Interim results from the WHO global respiratory syncytial virus surveillance pilot
    Siddhivinayak Hirve, Nigel Crawford, Rakhee Palekar, Wenqing Zhang on behalf of the WHO RSV surveillance Group (…, Maria Pisareva*, Elizaveta Smorodintseva*, …)
    Influenza and Other Respiratory Viruses — 2019. — Vol. . — Issue. . — pp. 1-11
    DOI: 10.1111/irv.12688
  13. Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019
    Segaloff H., Melidou A., Adlhoch C., Pereyaslov D., Emmanuel Robesyn E., Penttinen P., Olsen S.J., WHO European Region and the European Influenza Surveillance Network (…, Anna Sominina* and Elena Burtseva, …)
    Eurosurveillance — 2019. — Vol. 24. — Issue. 9. — pp. 1-8
    DOI: 10.2807/1560.7917.ES.2019.24.9.1900125
  14. Comparative Efficacy and Safety of Preventive Treatment With Cytovir-3 and Arbidol in Children During Seasonal Outbreak of Respiratory Viral Infection (An Open-Label Randomized Clinical Study)
    Smirnov V.S., Savelyev S.A., Petlenko S.V., Redlich G., Erofeeva* M.K., Lyovina A.V., Zaviyalova N.I.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 2. — pp. 273-278
    DOI: 10.15789/2220-7619-2019-2-273-278
  15. Diels-Alder adducts of 3-N-substituted derivatives of (-)-Cytisine as influenza A/H1N1 virus inhibitors; stereodifferentiation of antiviral properties and preliminary assessment of action mechanism
    Tsypysheva Inna, Koval'skaya Alena, Petrova Polina, Lobov Alexander, Borisevich Sophia, Tsypyshev Dmitry, Fedorova* Victoria, Gorbunova Elisaveta, Galochkina* Anastasia, Zarubaev Vladimir
    Tetrahedron — 2019. — Vol. 75. — Issue. 21. — pp. 2933-2943
    DOI: 10.1016/j.tet.2019.04.021
  16. DNA i-Motifs With Guanidino-i-Clamp Residues: The Counterplay Between Kinetics and Thermodynamics and Implications for the Design of pH Sensors
    Tsvetkov* Vladimir B., Zatsepin Timofei S., Turaev Anton V., Farzan Valentina M., Pozmogova Galina E., Aralov Andrey V., Varizhuk Anna M.
    Computational and Structural Biotechnology Journal — 2019. — Vol. 17. — Issue. . — pp. 527-536
    DOI: 10.1016/j.csbj.2019.04.006
  17. Effect of alpha-lactalbumin and lactoferrin oleic acid complexes on chromatin structural organization
    Lebedev Dmitry V, Zabrodskaya* Yana A., Pipich Vitaly, Kuklin Alexander I, Ramsay* Edward, Sokolov Alexey, V, Elizarova Anna Yu, Shaldzhyan* Aram A., Grudinina Natalia A., Pantina Rimma A., Wu Baohu, Shtam Tatiana A., Volnitskiy Andrey V., Schmidt Alexander E., Shvetsov Alexey, V, Vasilyev Vadim B., Isaev-Ivanov Vladimir V., Egorov* Vladimir V.
    Biochemical and Biophysical Research Communications — 2019. — Vol. 520. — Issue. 1. — pp. 136-139
    DOI: 10.1016/j.bbrc.2019.09.116
  18. Effect of Surfagon on Open Field and Elevated Plus Maze Behavior of Gonadectomized and Non-Gonadectomized Male Rats
    Masalova O.O., Kazakova S.B., Savateeva-Lyubimova* T.N., Sivak* K.V., Sapronov N.S., Shabanov P.D.
    Bulletin of Experimental Biology and Medicine — 2019. — Vol. 168. — Issue. 1. — pp. 52-54
    DOI: 10.1007/s10517-019-04644-4
  19. Efficient soluble expression and purification of influenza A and B nucleoproteins in E. coli
    Yolshin* N.D., Shaldzhyan* A.A., Klotchenko* S.A.
    Microbiology Independent Research (MIR) journal — 2019. — Vol. 6. — Issue. 1. — pp. 43-48
    DOI: 10.18527 / 2500-2236-2019-6-1-43-48
  20. Evaluation of Antiinflammatory Activity of 4'-O-Methylhonokiol Derivatives in a Neuroinflammation Model
    Sivak* K.V., Stosman* K.I., Muzhikyan* A.A., Alexandrov* A.G., Viktorov N.B., Vaulina D.D., Gomzina N.A.
    Russian Journal of Bioorganic Chemistry — 2019. — Vol. 45. — Issue. 5. — pp. 425-429
    DOI: 10.1134/S1068162019040113
  21. Exosomes as a promising tool for research and molecular diagnostics of myeloproliferative disorders
    Parfenenkova A.N., Barkhatov I.M., Kremlev A.A., Epifanovskaya O.A., Gorshkov* A.N., Vysochinskaya* V.V., Grudinin* M.P., Kornev A.A., Afanasyev B.V.
    Cellular Therapy and Transplantation — 2019. — Vol. 8. — Issue. 2. — pp. 74-81
    DOI: 10.18620/ctt-1866-8836-2019-8-2-74-81
  22. Features 2016-2018 Current Human Influenza A(H3N2) Viruses Circulating in Russia
    Petrova* P.A., Konovalova* N.I., Vassilieva* A.D., Eropkina* E.M., Ivanova* A.A., Komissarov* A.B., Eropkin* M.Yu, Danilenko* D.M.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 5-6. — pp. 655-664
    DOI: 10.15789/2220-7619-2019-5-6-655-664
  23. Features of Immune Response Against Influenza Infection in Animals Vaccinated with Recombinant Cross-Protective Vaccine
    Tsybalova* L.M., Stepanova* L.A., Korotkov* A.V, Shuklina* M.A., Zaitseva* M.V., Grishchenko V., I., Kotlyarov R.Yu.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 3-4. — pp. 485-494
    DOI: 10.15789/2220-7619-2019-3-4-485-494
  24. Generation and Characterization of the Monoclonal Antibody Panel Specific to the NS1 Protein of the Influenza A Virus
    Krivitskaya* V.Z., Sorokin* E.V., Tsareva* T.R., Sergeeva* M.V., Kadyrova* R.A., Romanovskaya-Roman'ko* E.A., Shaldzhyan* A.A., Petrov* S.V., Petrova* E.R., Konovalova* N.I., Petrova* P.A.
    Applied Biochemistry and Microbiology — 2019. — Vol. 54. — Issue. 7. — pp. 756-765
    DOI: 10.1134/S0003683818070049
  25. Hexon-Based Scaffold for Generation of Diagnostic Monoclonal Antibodies against Diverse Adenovirus Types (English abstract only)
    Timoshicheva* T.A., Zabrodskaya* Ya.A., Amosova* I.V.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 1. — pp. 47-56
    DOI: 10.15789/2220-7619-2019-1-47-56
  26. How to Fight Kinetics in Complex Radical Polymerization Processes: Theoretical Case Study of Poly(divinyl ether-alt-maleic anhydride)
    Bolshchikov Boris D., Tsvetkov* Vladimir B., Alikhanova Olga L., Serbin Alexander V.
    Macromolecular Chemistry and Physics — 2019. — Vol. 220. — Issue. 23. — pp. -1900389
    DOI: 10.1002/macp.201900389
  27. In Vitro Ceftaroline Resistance Selection of Methicillin-Resistant Staphylococcus aureus Involves Different Genetic Pathways
    Gostev Vladimir, Sopova Julia, Kalinogorskaya Olga, Tsvetkova Irina, Lobzin Yuri, Klotchenko* Sergey, Sidorenko Sergey
    Microbial Drug Resistance — 2019. — Vol. 25. — Issue. 10. — pp. 1401-1409
    DOI: 10.1089/mdr.2019.0130
  28. Increase in Sensitivity of HEK293FT Cells to Influenza Infection by CRISPR-Cas9-Mediated Knockout of IRF7 Transcription Factor
    A. B. Komissarov, M. V. Sergeeva, E. V. Mozhaeva, N. V. Eshchenko, A. D. Vasilieva, K. A. Vasilyev, S. P. Medvedev, A. A. Malakhova, E. A. Balakhonova, S. Yu. Malanin, T. V. Grigoryeva, E. S. Zhuravlev, D. V. Semenov, V. A. Richter and G. A. Stepanov
    Russian Journal of Bioorganic Chemistry — 2019. — Vol. 45. — Issue. . — pp. 749-757
    DOI: 10.1134/S1068162019060232
  29. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network
    Puig-Barbera Joan, Mira-Iglesias Ainara, Burtseva Elena, Cowling Benjamin J., Serhat Unal, Ruiz-Palacios Guillermo Miguel, Launay Odile, Kyncl Jan, Koul Parvaiz, Siqueira Marilda M., Sominina* Anna, & on behalf of the Global Influenza Hospital Surveillance Network (…, Afanasieva* O., Pisareva* M., Stolyarov* K., …)
    BMC Infectious Diseases — 2019. — Vol. 19. — Issue. . — pp. -415
    DOI: 10.1186/s12879-019-4017-0
  30. Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)
    Baselga-Moreno Victor, Trushakova Svetlana, McNeil Shelly, Sominina Anna*, Nunes Marta C., Draganescu Anca, Unal Serhat, Koul Parvaiz, Kyncl Jan, Zhang Tao, Kuatbayeva Ainagul, Ben-Salah Afif, Burtseva Elena, Puig-Barbera Joan, Diez-Domingo Javier, for The Global Influenza Hospital Surveillance Network (GIHSN) (..., Afanasieva* O., Afanasieva* A., Demina* S., Dondurei* E., Eropkin* M., Fadeev* A., Generalova* L., Go* A., Golovacheva* E., Gonchar* V., Komissarov* A., Konovalova* N., Kuvarzina* S., Levanyuk* T., Lobova* T., Osidak* L., Pisareva* M., Rozhkova* E., Sintsova* K., Sirotkina* Z., Smorodintseva* E., Stolyarov* K., Sukhovetskaya* V., Tamila* M., Voloshuk* L., Yanina* M., …)
    BMC Public Health — 2019. — Vol. 19. — Issue. . — pp. -487
    DOI: 10.1186/s12889-019-6713-5
  31. Long-Term Maintenance of the Functional Changes Induced by Influenza A Virus and/or LPS in Human Endothelial ECV-304 Cell Sublines
    S. S. Smirnova, M. M. Pisareva, T. D. Smirnova, K. V. Sivak & K. V. Vorobiev
    Cell and Tissue Biology — 2019. — Vol. 13. — Issue. . — pp. 283-291
    DOI: 10.1134/S1990519X19040084
  32. Meglumine acridone acetate, the ionic salt of CMA and N-methylglucamine, induces apoptosis in human PBMCs via the mitochondrial pathway
    Plotnikova* Marina A., Klotchenko* Sergey A., Kiselev Artem A., Gorshkov* Andrey N., Shurygina* Anna-Polina S., Vasilyev* Kirill A., Uciechowska-Kaczmarzyk Urszula, Samsonov Sergey A., Kovalenko Alexey L., Vasin* Andrey V.
    Scientific Reports — 2019. — Vol. 9. — Issue. . — pp. -18240
    DOI: 10.1038/s41598-019-54208-9
  33. Microneutralization Reaction Compared to Hemagglutination Inhibition Assay to Evaluate Immunogenicity of Influenza Vaccines and Influenza Diagnostics
    Krivitskaya* V.Z., Kuznecova* E.V., Majorova* V.G., Kadyrova* R.A., Lvov N.I, Go* A.A., Sominina* A.A.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 5-6. — pp. 763-772
    DOI: 10.15789/2220-7619-2019-5-6-763-772
  34. Morphological study of telocytes in the left atrium in patients with long-term persistent atrial fibrillation (English abstract only)
    Mitrofanova L.B., Khazratov A.O., Gurshchenkov A.V., Osadchii A.M., Gorshkov* A.N., Galkovsky B.E.
    Russian Journal of Cardiology — 2019. — Vol. 24. — Issue. 7. — pp. 53-62
    DOI: 10.15829/1560-4071-2019-7-53-62
  35. New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties
    Volodina Yulia L., Dezhenkova Lyubov G., Tikhomirov Alexander S., Tatarskiy Victor V., Kaluzhny Dmitry N., Moisenovich Anastasia M., Moisenovich Mikhail M., Isagulieva Alexandra K., Shtil Alexander A., Tsvetkov* Vladimir B., Shchekotikhin Andrey E.
    European Journal of Medicinal Chemistry — 2019. — Vol. 165. — Issue. . — pp. 31-45
    DOI: 10.1016/j.ejmech.2018.12.068
  36. p62/SQSTM1 expression in canine mammary tumours: Evolutionary notes
    Mariotti Francesca, Magi, Gian Enrico, Gavazza Alessandra, Vincenzetti, Silvia, Komissarov* Andrey, Shneider Alex, Venanzi Franco Maria
    Veterinary and Comparative Oncology — 2019. — Vol. 17. — Issue. 4. — pp. 570-577
    DOI: 10.1111/vco.12523
  37. Pathology of A(H5N8) (Clade 2.3.4.4) Virus in Experimentally Infected Chickens and Mice
    E.A. Prokopyeva, V.A. Zinserling, Y.-C. Bae, Y. Kwon, O.G. Kurskaya, I.A. Sobolev, P.M. Kozhin, A. Komissarov*, A.Fadeev*, V.Petrov, A.M. Shestopalov, K.A. Sharshov
    Interdisciplinary Perspectives on Infectious Diseases — 2019. — Vol. . — Issue. Article ID 4124865. — pp. -
    DOI: 10.1155/2019/4124865
  38. Peculiarities of free-radical processes and neurupsychological status in patients with chronic generalized periodontitis and possibility of correcting their impairments with antioxidant therapy
    Saulin M.P., Bolevich S., Savateeva-Liubimova* T., Sivak* K., Silina E.
    Serbian Journal of Experimental and Clinical Research — 2019. — Vol. 20. — Issue. 2. — pp. 55-64
    DOI: 10.2478/sjecr-2019-0034
  39. Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling
    Shtam Tatiana, Naryzhny Stanislav, Samsonov Roman, Karasik David, Mizgirev Igor, Kopylov Artur, Petrenko Elena, Zabrodskaya* Yana, Kamyshinsky Roman, Nikitin Daniil, Sorokin Maxim, Buzdin Anton, Gil-Henn Hava, Malek Anastasia
    Breast Cancer Research and Treatment — 2019. — Vol. 174. — Issue. 1. — pp. 129-141
    DOI: 10.1007/s10549-018-5043-0
  40. Probing the Nitroindole-Modified Central Loop of Thrombin Aptamer HD1 as a Recognition Site
    Kolganova Natalia A., Tsvetkov* Vladimir B., Smirnov Igor P., Timofeev Edward N.
    Nucleic Acid Therapeutics — 2019. — Vol. 29. — Issue. 4. — pp. 208-217
    DOI: 10.1089/nat.2018.0757
  41. Probing the Nitroindole-Modified Central Loop of Thrombin Aptamer HD1 as a Recognition Site
    Natalia A. Kolganova, Vladimir B. Tsvetkov*, Igor P. Smirnov, and Edward N. Timofeev
    Nucleic Acid Therapeutics — 2019. — Vol. 29. — Issue. 4. — pp. -
    DOI: 10.1089/nat.2018.0757
  42. Regulation of Aggregation of Self-Associated Peptides, Including N-Terminal Fragments of the Alzheimer's beta-Amyloid Peptide, by Nitro Derivatives of Azoloazine (vol 44, pg 665, 2018)
    Mirgorodskaya* O.A., Kozmin Y.P., Protasov* A.V., Toropygin I.Y., Oleinikov V.A.
    Russian Journal of Bioorganic Chemistry — 2019. — Vol. 45. — Issue. 5. — pp. 430-430
    DOI: 10.1134/S1068162019010096
  43. Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers
    Timin A.S., Peltek O.O., Zyuzin M.V., Muslimov* A.R., Karpov T.E., Epifanovskaya O.S., Shakirova A.I., Zhukov M.V., Tarakanchikova Y.V., Lepik K.V., Sergeev V.S., Sukhorukov G.B., Afanasyev B.V.
    ACS Applied Materials and Interfaces — 2019. — Vol. 11. — Issue. 14. — pp. 13091-13104
    DOI: 10.1021/acsami.8b22685
  44. Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1
    Nicolodi Christina, Groiss Franz, Kiselev* Oleg, Wolschek Markus, Seipelt Joachim, Muster Thomas
    Vaccine — 2019. — Vol. 37. — Issue. 28. — pp. 3722-3729
    DOI: 10.1016/j.vaccine.2019.05.013
  45. Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
    Isakova-Sivak Irina, Matyushenko Victoria, Kotomina Tatiana, Kiseleva Irina, Krutikova Elena, Donina Svetlana, Rekstin Andrey, Larionova, Natalia, Mezhenskaya Daria, Sivak* Konstantin, Muzhikyan* Arman, Katelnikova Anastasia, Rudenko Larisa
    Vaccines — 2019. — Vol. 7. — Issue. 3. — pp. -61
    DOI: 10.3390/vaccines7030061
  46. Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.
    Krupitsky E, Blokhina E, Zvartau E, Verbitskaya E, Lioznov* D, Yaroslavtseva T, Palatkin V, Vetrova M, Bushara N, Burakov A, Masalov D, Mamontova O, Langleben D, Poole S, Gross R, Woody G.
    The Lancet HIV — 2019. — Vol. 6. — Issue. 4. — pp. -
    DOI: 10.1016/S2352-3018(18)30362-X
  47. Spontaneous Proteolytic Processing of Human Recombinant Anti-Mullerian Hormone: Structural and Functional Differences of the Molecular Forms
    Rak A.Ya., Trofimov A.V., Protasov E.A., Rodin S.V., Zhahov A.V., Zabrodskaya* Ya.A., Ischenko A.M.
    Applied Biochemistry and Microbiology — 2019. — Vol. 55. — Issue. 1. — pp. 13-20
    DOI: 10.1134/S0003683819010149
  48. Synthesis and Antimicrobial Activity of Adamantyl Substituted Pyridoxine Derivatives
    Khaziev Rail, Shtyrlin Nikita, Pavelyev Roman, Nigmatullin Raushan, Gabbasova Raylya, Grishaev Denis, Shtro Anna, Galochkina* Anastasia, Nikolaeva Yulia, Vinogradova Tatiana, Manicheva Olga, Dogonadze Marine, Gnezdilov Oleg, Sokolovich Evgenii, Yablonskiy Petr, Balakin Konstantin, Shtyrlin Yurii
    Letters In Drug Design & Discovery — 2019. — Vol. 16. — Issue. 12. — pp. 1360-1369
    DOI: 10.2174/1570180816666190911150705
  49. Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents
    Yarovaya Olga, I, Sokolova Anastasiya S., Mainagashev Iliya Ya, Volobueva Alexandrina S., Lantseva Khristina, Borisevich Sophia S., Shtro* Anna A., Zarubaev Vladimir V., Salakhutdinov Nariman F.
    Bioorganic & Medicinal Chemistry Letters — 2019. — Vol. 29. — Issue. 23. — pp. -126745
    DOI: 10.1016/j.bmcl.2019.126745
  50. Synthesis of C5-C6 Derivatives of 1,3-Dimethyl-5-Fluorouracil and 5-Fluorouracil. Screening for Antiviral Activity
    Chernikova I.B., Khursan S.L., Eropkin* M.Yu., Yunusov M.S.
    Pharmaceutical Chemistry Journal — 2019. — Vol. 53. — Issue. 2. — pp. 108-112
    DOI: 10.1007/s11094-019-01962-9
  51. Synthesis of New 4,4a-Dihydroxanthones via [4+2]-Cycloaddition Reaction
    Chernov N.M., Moroz T.V., Shutov R.V., Kuz'mich* N.N., Shchegolev A.E., Sopova M.V., Yakovlev I.P.
    Russian Journal of General Chemistry — 2019. — Vol. 89. — Issue. 12. — pp. 2463-2470
    DOI: 10.1134/S1070363219120223
  52. The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections
    Klausberger Miriam, Leneva Irina A., Falynskova Irina N., Vasiliev* Kirill, Poddubikov Alexander V., Lindner Claudia, Kartaschova Nadezhda P., Svitich Oxana A., Stukova* Marina, Grabherr, Reingard, Egorov* Andrej
    Vaccines — 2019. — Vol. 7. — Issue. 4. — pp. -187
    DOI: 10.3390/vaccines7040187
  53. Use of hexon as an antigen for the production of monoclonal antibodies capable of detecting multiple adenovirus types
    Timoshicheva* Tatyana A., Zabrodskaya* Yana A., Ramsay* Edward, Amosova* Irina V.
    Biologicals — 2019. — Vol. 58. — Issue. . — pp. 44-49
    DOI: 10.1016/j.biologicals.2019.01.006
  54. Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naive persons with alcohol use in Russia
    Barocas Joshua A., So-Armah Kaku, Cheng Debbie M., Lioznov* Dmitry, Baum Marianna, Gallagher Kerrin, Fuster Daniel, Gnatienko Natalia, Krupitsky Evgeny, Freiberg Matthew S., Samet Jeffrey H.
    Plos One — 2019. — Vol. 14. — Issue. 6. — pp. -
    DOI: 10.1371/journal.pone.0218852

2018

  1. Effect of Shock Waves Generated by Pulsed Electric Discharges in Water on Yeast Cells and Virus Particles
    Girdyuk, A. E.; Gorshkov, A. N.; Egorov, V. V.; Kolikov, V. A.; Snetov, V. N.; Shneerson, G. A.
    Technical Physics. – 2018. – Volume 63, Issue 2, pp. 285–290 
  2. Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia
    Gnatienko, N.; Freiberg, M. S.; Blokhina, E.; Yaroslavtseva, T.; Bridden, C.;  Cheng, D. M.; Chaisson, C. E.; Lioznov, D.; Bendiks, S.; Koerbel, G.; Coleman, S. M.; Krupitsky, Ev.; Samet, J. H.
    HIV Clinical Trials.– 2018. – Volume 19, Issue 3, pp. 101-111
  3. Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses
    Ilyina, I. V; Zarubaev, V. V.; Lavrentieva, I. N.; Shtro, A. A.; Esaulkova, Ia. L.; Korchagina, D. V.; Borisevich, S. S.; Volcho, K. P.; Salakhutdinov, N. F.
    Bioorganic & Medicinal Chemistry Letters. - 2018.-  Volume 28, Issue 11, pp. 2061-2067
  4. beta-D-Ribofuranosyl substituted polyfluoroalkylpyrazoles and their activity against the influenza virus
    Ivanova, A. E.; Burgart, Ya. V.; Saloutin, V. I.; Orshanskaya, Ya. R.; Zarubaev, V. V.
    Mendeleev Communications.- 2018. - Volume 28, Issue 1, pp. 52-54
  5. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18 (vol 35, pg 4828, 2017)
    Melidou, A.; Broberg, E.; Adlhoch, C.; Snacken, R.; Penttinen, P.; Pereyaslov, D., Brown, C,;… European Region Influenza Surveill
    Vaccine. - 2018. - Volume 36, Issue 19, pp. 2740-2741
  6. Telocytes in the human sinoatrial node
    Mitrofanova, L. B.; Gorshkov, A. N.; Konovalov, P. V.; Krylova, J. S.
    Journal of Cellular and Molecular Medicine. - 2018. - Volume 22, Issue 1, pp. 521-532
  7. Synthesis and Biological Activity of 16,33-O,O-Diformyl-16,17-dihydro-16(S),17(R)-dihydroxyoligomycin A and 33-O-Formyloligomycin A
    Omelchuk, O. A.; Belov, N. M.; Tsvetkov, V. B.; Korolev, A. M.; Dezhenkova, L. G.; Grammatikova,N. E.; Lysenkova, L. N.; Bekker, O. B.; Danilenko, V. N.; Shchekotikhin, A. E.
    Macroheterocycles. - 2018. - Volume 11, Issue 2, pp. 181-192
  8. Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults
    Sarsenbayeva, G. Volgin, Ye; Kassenov, M.; Issagulov, Tr.; Bogdanov, N.; Sansyzbay, A.; Stukova, M.; Buzitskaya, Zh.; Kulmagambetov, I.; Davlyatshin, T.; Khairullin, B.
    Human Vaccines & Immunotherapeutics.- 2018. - Volume 14, Issue 3, SI, pp. 609-614
  9. Y Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial
    Sarsenbayeva, G.; Volgin, Ye.; Kassenov, M.; Issagulov, T.; Bogdanov, N.; Sansyzbay, A.; Abitay, R.; Nurpeisova, A.; Sagymbay, A.; Koshemetov, Z.; Stukova, M.; Buzitskaya, Zh.; ulmagambetov, I.; Karabayeva, D.; Davlyatshin, T.; Khairullin, B.
    Journal of Medical Virology. - 2018. - Volume 90, Issue 1, pp. 41-49
  10. Influence of the linking order of fragments of HA2 and M2e of the influenza A virus to flagellin on the properties of recombinant proteins
    Stepanova, L. A., Kotlyarov, R. Y., Shuklina, M. A., (...), Ravin, N. V., Tsybalova, L. M.
    Acta Naturae. - 2018. - Volume 10, Issue 1, pp. 85-94
    DOI
  11. Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes
    Stepanova, L. A.; Mardanova, Eu. S.; Shuklina, M. A.; Blokhina, E. A.; Kotlyarov, R. Y.; Potapchuk, M. V.; Kovaleva, A. A.; Vidyaeva, I. G.; Korotkov, A.r V.; Eletskaya, E. I.; Ravin, N.i V.; Tsybalova, L. M.
    Journal of Biomedical Science. - 2018. - Volume 25 : 33
  12. i-Clamp phenoxazine for the fine tuning of DNA i-motif stability
    Tsvetkov, V.  B.; Zatsepin, T. S.; Belyaev, E. S.; Kostyukevich, Y. I.; Shpakovski, G. V.; Podgorsky, V. V.; Pozmogova, G. E.; Varizhuk, A. M.; Aralov, A. V.
    Nucleic Acids Research.- 2018. - Volume 46, Issue 6, pp. 2751-2764
  13. Synthesis of Silver Glyconanoparticles Based on 3-Thiopropionylhydrazones of Mono- and Disaccharides 
    Vasileva, M. Yu.; Ershov, A. Yu.; Baigildin, V. A.; Lagoda, I. V.; Kuleshova, L. Yu.; Shtro, A. A.; Zarubaev, V. V.; Yakimanskii, A. V.
    Russian Journal of General Chemistry. - 2018. - Volume 88, Issue 1, pp. 109-113
  14. First example of the cascade acylation/IMDAViene reaction sequence, leading to N-arylbenzo[f]isoindole-4-carboxylic acids possessing anti-viral activity
    Voronov, A. A.; Alekseeva, K. A.; Ryzhkova, E. A.; Zarubaev, V. V.; Galochkina, A. V.; Zaytsev, V. P.; Majik, Mahesh S.; Tilve, Santosh G.; Gurbanov, Atash V.; Zubkov, F. I.
    Tetrahedron Letters.- 2018. - Volume 59, Issue 12, pp. 108-1111
  15. The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity
    Zabrodskay, Ya. A.; Lebedev, D. V.; Egorova, M. A.; Shaldzhyan, A. A.; Shvetsov, A. V.; Kuklin, A. I.; Vinogradova, D. S.; Klopov, N. V.; Matusevich, O. V.; Cheremnykh, T. A.; Dattani, R.; Egorov, V. V.
    Biophysical Chemistry. - 2018. - Volume 234, pp. 16-23
  16. Changing Times: Fluorescence-Lifetime Analysis of Amyloidogenic SF-IAPP Fusion  Protein
    Antimonova, O. I Lebedev, D. V Zabrodskaya, Ya. A Grudinina, N. A Timkovsky, A. L Ramsay, E. Shavlovsky, M. M Egorov V. V.
    Journal of Structural Biology. - 2018
  17. Conserved RNA secondary structure of the NS segment as a possible additional influenza viral pathogenicity factor
    Baranovskaya, I.; Sergeeva, M.; Brodskaia, A.; Taraskin, A.; Vasin, A.
    FEBS OPEN BIO. - 2018. - Volume: 8. : 1. - P. 204
  18. Expression in Plants of a Recombinant Protein Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin of Influenza Virus
    Blokhina, E. A.; Mardanova, E. S.; Tsybalova, L. M.; Ravin, N. V.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY. - 2018. - Volume 54, Issue 4. - P. 404-409
  19. Practical procedure for a theoretical investigation of thermodynamics and kinetics aspects of different-scale radical reactions from addition and cyclization to cyclocopolymerization involving maleic anhydride and divinyl ether
    Bolshchikov, B. D.; Tsvetkov, V. B.; Serbin, A. V.
    POLYMER. - 2018. - Volume 146. - P. 429-445
  20. Female Gender and HIV Transmission Risk Behaviors Among People Living with HIV Who Have Ever Used Injection Drugs in St. Petersburg, Russia
    Wagman, Jennifer A.; Samet, Jeffrey H.; Cheng, Debbie M.; Gnatienko, Natalia; Raj, Anita; Blokhina, Elena; Toussova, Olga; Forman, Leah S.; Lioznov, Dmitry; Tsui, Judith I.
    AIDS AND BEHAVIOR. - 2018. - Volume 22. - Issue 9. - P.2830-2839
  21. Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity
    Zarubaev, V. V.; Pushkina, E. A.; Borisevich, S. S.; Galochkina, A. V.; Garshinina, A. V.; Shtro, Anna A.; Egorova, Anna A.; Sokolova, A. S.; Khursan, Sergey L.; Yarovaya, Olga I.; Salakhutdinov, N. F.
    VIROLOGY. - 2018. - Volume 524. - P. 69-77
  22. A double-edged sword: supramolecular complexes of triazavirine display multicenter binding effects which influence aggregate formation
    Zabrodskaya, Ya.A., Shvetsov,A.V., Tsvetkov, V.B. Egorov, V. V.
    Journal of Biomolecular Structure and Dynamics. - 2018. - Aug 3. - P. 1-19 
  23. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
    Tsybalova, L. M.; Stepanova, L. A.; Shuklina, M. A.; Mardanova, E. S.; Kotlyarov, R. Y.; Potapchuk, M., V; Petrov, Sergei A.; Blokhina, Elena A.; Ravin, Nikolai, V
    PLOS ONE. - 2018. - Volume 13. - Issue 8,  Article № e0201429
  24. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriersI
    Brodskaia, A. V; Timin, A S.; Gorshkov, A N.;
    Antiviral Research. - 2018. - Volume 158. - P. 147-160 
  25. Comparative study of diethylaminoethyl-chitosan and methylglycol-chitosan as potential non-viral vectors for gene therapy
    Raik S.V., Petrova V.A., Kritchenkov A.S., Skorik Y.A., Andranovitš S., Casettari L., Xu Y., Lam J.K.- W., Morris G.A., Brodskaia A.V.
    Polymers. - 2018. - Volume 10. - Issue 4. - P. 442
  26. Functional Properties of Circulating Exosomes Mediated by Surface-Attached Plasma Proteins
    Shtam ., Naryzhny S., Kopylov A., Petrenko E., Samsonov R., Kamyshinsky R. , Zabrodskaya Ya., Nikitin D., Sorokin M., Buzdin A., Malek A.
    J Hematol. - 2018. - Volume 7. - Issue 4. - P. 149-153 
  27. The European Virus Archive goes global: A growing resource for research
    Romette, J. L.; Prat, C. M.; Gould, E. A…, Eropkin, M.Y.
    Antiviral Research. - 2018. - Volume 158. - P. 127-134
  28. Novel 18-crown-6-ether containing mono- and bisstyryl dyes derived from pyridine moiety as fluorescent dyes for non-covalent interaction with DNA
    Lebedeva, A. Y.; Fedorova, O.A.; Tsvetkov, V. B.;  Grinberg, V. Y.; Grinberg, N. V.;  Burova, T.V.; Dubovik, A.S.; Babievsky, K.K.; Fedorov, Y. V.
    Antiviral Research. - 2018. - Volume 158. - P. 147-160 
  29. Cross-protective efficacy of monovalent live influenza B vaccines against genetically different lineages of B/Victoria and B/Yamagata in ferrets
    Kiseleva I., Krutikova E., Stepanova E., Donina S., Pisareva M.,  Krivitskaya V., Rekstin A., Grace Sparrow E., Torelli G., Rudenko L.
    DYES AND PIGMENTS. - 2018. - Volume 157. - P. 80-92
  30. False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts
    Coleman S.M., Lloyd-Travaglini C.A., Winter M.R., Gnatienko N., Bridden C., Samet J.H., Blokhina E., Lioznov D., Adong J.,  Liegler T., Hahn J.A.
    HIV Clinical Trials. - 2018. - Volume 19. - Issue 1. - P. 15-22
  31. The influence of hydrodynamic conditions and chamber geometry on the analytical signal from integrated biochips
    Esikova, N.A., Bulyanitsa, A.L., Klotchenko, S.A., Taraskin, A.S., Evstrapov, A.A.
    Journal of Physics: Conference Series. - 2018. - 1135(1). - 012021
  32. Antiviral activity of Embelia ribes Burm. f. against influenza virus in vitro
    Hossan, Md Sh.; Fatima, A.; Rahmatullah, M.; Khoo, T. J.; Nissapatorn, V.; Galochkina, A. V.; Slita, A. V.; Shtro, A. A.; Nikolaeva, Yu.; Zarubaev, V. V.; Wiart, Ch.
    ARCHIVES OF VIROLOGY. - 2018. - Volume 163. - Issue 8. - P. 2121-2131
  33. Psychological features of abstinent heroin users before and after rehabilitation in Saint Petersburg, Russia
    Galankin T., Lioznov D., Nikolaenko S., McNutt L.A., Leckman-Westin E., Smith P.F.
    BMC Research Notes. - 2018. - Volume 11. - Issue 1. - P. 589
  34. Serodiscordant partnerships and opportunities for pre-exposure prophylaxis among partners of women and men living with HIV in St. Petersburg, Russia
    Gnatienko N, Wagman JA, Cheng DM, Bazzi AR, Raj A, Blokhina E, Toussova O, Forman LS, Lioznov D, Bridden C, Sullivan M, Bryant K, Samet JH, Tsui JI.
    PLoS One. 2018 Nov 16;13(11):e0207402 

2017

* denotes publications with non–RII co–authors.

Research papers:

  1. Features of the terahertz spectra of iron oxide nanoparticles in a silicon dioxide shell and of iron oxide and hydroxide nanoparticles
    Afonin V., Balbekin N.S., Gareev G.Z., Gareev K.G., Gorshkov A.N., Korolev D.V., Luchinin V.V., Smolyanskaya O.A.
    Journal of Optical Technology. – 2017. – Vol. 84, Issue 8, pp. 515-520
    DOI / PubMed Abstract
  2. Synthetic Route to 4,4a- and 3,4-Dihydroxanthones through [4+2] Cycloaddition and Base-Assisted Sigmatropic Rearrangement
    Chernov N, Shutov R, Sharoyko V, Kuzmich N, Belyakov A, Yakovlev I. *
    European Journal of Organic Chemistry. – 2017. – Volume 2017, Issue 19, May 18, Pages 2836–2841
    DOI / PubMed Abstract
  3. Structural features of the ionic self-complementary amyloidogenic peptide
    Egorov V V, Zabrodskaya Ya A, Lebedev D V, Gorshkov A N and Kuklin A I *
    IOP Conf. Series: Journal of Physics. – 2017. – Conf. Series 848 012022
    DOI / PubMed Abstract
  4. Synthesis and antiviral activity of novel glycyrrhizic acid conjugates with D-amino acid esters
    Fayrushina A.I., Baltina Jr. L.A., Baltina L.A., Konovalova N.I., Petrova P.A., Eropkin M.Yu. *
    Russian Journal of Bioorganic Chemistry. – 2017. – Volume 43, Issue 4, pp 456–462
    DOI / PubMed Abstract
  5. Modern approaches for identification of modified nucleotides in RNA
    Filippova J.A., Semenov D.V., Juravlev E.S., Komissarov A.B., Richter V.A., Stepanov G.A.
    Biochemistry. – 2017. – Volume 82, Issue 11, pp 1217–1233
    DOI / PubMed Abstract
  6. A comparison study between electrospun polycaprolactone and piezoelectric poly(3-hydroxybutyrate-co-3-hydroxyvalerate) scaffolds for bone tissue engineering
    Gorodzha S.N., Muslimov A.R., Syromotina D.S., Timin A.S., Tcvetkov N.Y., Lepik K.V., Petrova A.V., Surmeneva M.A., Gorin D.A., Sukhorukov G.B., Surmenev R.A. *
    Colloids and Surfaces B: Biointerfaces. – 2017. – Volume 160, 1 December 2017, Pages 48-59
    DOI / PubMed Abstract
  7. P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions
    Halenova T., Savchuk O., Ostapchenko L., Chursov A., Fridlyand N., Komissarov A.B., Venanzi F., Kolesnikov S.I.,  Sufianov A.A., Sherman M.Y., Gabai V.L. and Shneider A.M. *
    Oncotarget. – 2017. – 8:56030-56040
    DOI / PubMed abstract
  8. Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivo
    Hock K., Laengle J., Kuznetsova I., Egorov A., Hegedus B., Dome B., Wekerle T., Sachet M., Bergmann M. *
    Surgery. – 2017. – Volume 161, Issue 3, Pages 735–746
    DOI / PubMed abstract
  9. Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses
    Komissarov A., Fadeev A., Kosheleva A., Grudinin M.
    Molecular and Cellular Probes. – 2017. – Volume 35, October 2017, Pages 57-63
    DOI / PubMed abstract
  10. Synthesis of Conjugates of Lupane-Type Pentacyclic Triterpenoids with 2-Aminoethane- and N-Methyl-2-Aminoethanesulfonic Acids. Assessment of in vitro Toxicity
    Komissarova N.G., Dubovitskii S.N., Shitikova O.V., Vyrypaev E.M., Spirikhin L.V., Eropkina E.M., Lobova T.G., Eropkin M.Yu., Yunusov M.S. *
    Chemistry of Natural Compounds. – 2017. – September 2017, Volume 53, Issue 5,  pp 907–914
    DOI / PubMed Abstract
  11. Synthesis of new heterocyclic dehydroabietylamine derivatives and their biological activity
    Kovaleva K.S., Yarovaya O.I., Shernyukov A.V., Zarubaev V.V., Shtro A.A., Orshanskaya Y.R., Salakhutdinov N.F. *
    Chemistry of Natural Compounds. – 2017. – Volume 53, Issue 3, pp 364–370
    DOI / PubMed abstract
  12. Alzheimer’s disease: as it was in the beginning
    Kozlov S., Afonin A., Evsyukov I., Bondarenko A. *
    Reviews in the Neurosciences. – 2017. – 07-12
    DOI / PubMed Abstract
  13. TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
    Kuzmich N.N., Sivak K.V., Chubarev V.N., Porozov Y.B., Savateeva-Lyubimova T.N., Peri F. *
    Vaccines. – 2017. – 5(4), 34
    DOI / PubMed Abstract
  14. Targeting an oncolytic influenza A virus to tumor tissue by elastase
    Kuznetsova I., Arnold T., Aschacher T., Schwager C., Hegedus B., Garay T., Stukova M., Pisareva M., Pleschka S., Bergmann M., Egorov A. *
    Molecular Therapy - Oncolytics. – 2017. – Volume 7, 15 December 2017, Pages 37-44
    DOI / PubMed Abstract
  15. Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A
    Lysenkova L.N., Saveljev O.Y., Grammatikova N.E., Tsvetkov V.B., Bekker O.B., Danilenko V.N., Dezhenkova L.G., Bykov E.E., Omelchuk O.A., Korolev A.M., Shchekotikhin A.E. *
    The Journal of Antibiotics. – 2017. – April 19
    DOI / PubMed abstract
  16. Reintroduction of highly pathogenic avian influenza A/H5N8 virus of clade 2.3.4.4. in Russia
    Marchenko V.Y., Susloparov I.M., Komissarov A.B., Fadeev A., Goncharova N.I., Shipovalov A.V., Svyatchenko S.V., Durymanov A.G., Ilyicheva T.N., Salchak L.K., Svintitskaya E.P., Mikheev V.N., Ryzhikov A.B. *
    Archives of Virology. – 2017. – pp 1–5
    DOI / PubMed abstract
  17. Efficient Transient Expression of Recombinant Proteins in Plants by the Novel pEff Vector Based on the Genome of Potato Virus X
    Mardanova E.S., Blokhina E.A., Tsybalova L.M., Peyret H., Lomonossoff G.P. and Ravin N.V. *
    Front. Plant Sci. – 2017. – 8:247
    DOI / PubMed Abstract
  18. Mesenchymal Stem Cells Engineering: Microcapsules-Assisted Gene Transfection and Magnetic Cell Separation
    Muslimov A.R., Timin A.S., Petrova A.V., Epifanovskaya O.S., Shakirova A.I., Lepik K.V., Gorshkov A., Il’inskaja E.V., Vasin A.V., Afanasyev B.V., Fehse B., Sukhorukov G.B. *
    ACS Biomaterials Science. – 2017. – 3 (10), pp 2314–2324
    DOI / PubMed Abstract
  19. Influenza Antiviral Activity of Br-Containing [2R,4R(S),4aR,7R,8aR]-4,7-Dimethyl-2-(Thiophen-2-YL)Octahydro-2H-Chromen-4-Ols Prepared from (–)-Isopulegol
    Nazimova E.V., Shtro A.A., Anikin V.B., Patrusheva O.S., Il′ina I.V., Korchagina D.V., Zarubaev V.V., Volcho K.P., Salakhutdinov N.F. *
    Chemistry of Natural Compounds. – 2017. – Volume 53, Issue 2, pp 260–264
    DOI / PubMed abstract
  20. Ceruloplasmin gene expression profile changes in the rat mammary gland during pregnancy, lactation and involution
    Platonova N.A., Orlov I.A., Klotchenko S.A., Babich V.S., Ilyechova E.Y., Babich P.S., Garmai Y.P., Vasin A.V., Tsymbalenko N.V., Puchkova L.V. *
    Journal of Trace Elements in Medicine and Biology. – 2017. – Volume 43, September 2017, Pages 126-134
    DOI / PubMed abstract
  21. Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors
    Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Manikhas GM, Zyryanov AV, Burkhanova LA, Badrtdinova II, Oshchepkov BN, Filippova EV, Orlov SV, Kolesnikov SI, Sufianov AA, Baum SR, Zaitzeva OY, Komissarov AB, Grudinin MP, Kiselev OI, Tsyb AF, Venanzi F, Shcherbinina V, Chursov A, Gabai VL, Shneider AM *
    Oncotarget. – 2017. – 8:53730-53739
    DOI / PubMed abstract
  22. Impact of mutations in nucleoprotein on replication of influenza virus A/Hong Kong/1/68/162/35 reassortants at different temperatures
    Pulkina A.A., Sergeeva M.V., Petrov S.V., Fadeev A.V., Komissarov A.B., Romanovskaya-Romanko E.A., Potapchuk M.V., Tsybalova L.M.
    Molecular Biology. – 2017. – Volume 51, Issue 2, pp 333–338
    DOI / PubMed abstract
  23. A novel preservative-free seasonal influenza vaccine safety and immune response study in the frame of preclinical research
    Sarsenbayeva G, Volgin Y, Kassenov M, Issagulov T, Bogdanov N, Nurpeisova A, Sagymbay A, Abitay R, Stukova M, Sansyzbay A, Khairullin B
    Journal of Medical Virology. – 2017. – Jul;89(7):1168-1173
    DOI / PubMed Abstract  
  24. The Oxime Derivatives of 1-R-1H-Naphtho[2.3-d][1.2.3]triazole-4.9-dione 2-oxides: Synthesis and Properties
    Shtil AA, Gornostaev LM, Tsvetkov VB, Markova AA, Lavrikova TI, Khalyavina YG, Kuznetsova AS, Kaluzhny DN, Shunayev AV, Tsvetkova MV, Glazunova VA, Chernyshev VV *
    Anticancer Agents Med Chem. – 2017. – Vol 17
    DOI / PubMed abstract
  25. Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure
    Shvetsov A., Zabrodskaya Y., Nekrasov P., Egorov V. *
    Journal of Biomolecular Structure and Dynamics. – 2017. – Published online: 12 Sep 2017, pp 1-5
    DOI / PubMed Abstract
  26. Regio- and diastereoselectivity of the cycloaddition of aldonitrones with benzylidenecyclopropane: An experimental and theoretical study
    Sirotkina EV, Efremova MM, Novikov AS, Zarubaev VV, Orshanskaya IR, Starova GL, Kostikov RR, Molchanov AP *
    Tetrahedron. – 2017. – Volume 73, Issue 21, Pages 3025–3030
    DOI / PubMed abstract
  27. Effect of influenza A virus and bacterial lipopolysaccharide on proliferation and expression of cytokines and other cellular factors in the endothelial cell line ECV-304
    Smirnova S.S., Pisareva M.M., Smirnova T.D., Plotnikova M.A., Sivak K.V., Vorobiev K.V. *

    Cell and Tissue Biology. – 2017. – Volume 11, Issue 2, pp 147–154
    DOI / PubMed abstract
  28. Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus
    Sokolova  A. S., Yarovaya O. I., Semenova M.D., Shtro A. A., Orshanskaya I.R., Zarubaev V. V.  and  Salakhutdinov N.F. *
    MedChemComm. – 2017. – 8(5), Pages 960—963
    DOI / PubMed Abstract
  29. Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1
    Sokolova A.S., Yarovaya O.I, Baev D.S., Shernyukov A.V., Shtro A.A., Zarubaev V.V., Salakhutdinov N.F. *
    European Journal of Medicinal Chemistry. – 2017. – Volume 127, Pages 661–670
    DOI / PubMed abstract
  30. Synthesis and biological activity of heterocyclic borneol derivatives
    Sokolova A.S., Yarovaya O.I., Shtro A.A., Borisova M.S., Morozova E.A., Tolstikova T.G., Zarubaev V.V., Salakhutdinov N.F. *
    Chemistry of Natural Compounds. – 2017. – Volume 53, Issue 3, pp 371–377
    DOI / PubMed abstract
  31. Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection
    Timin A.S., Muslimov A.R., Petrova A.V., Lepik K.V., Okilova M.V., Vasin A.V., Afanasyev B.V., Sukhorukov G.B. *
    Scientific Reports. – 2017. – 7, Article number: 102
    DOI / PubMed abstract
  32. In vitro toxicity of FemOn, FemOn-SiO2 composite, and SiO2-FemOn core-shell magnetic nanoparticles
    Toropova Y.G., Golovkin A.S., Malashicheva A.B., Korolev D.V., Gorshkov A.N., Gareev K.G., Afonin M.V., Galagudza M.M. *
    International Journal of Nanomedicine. – 2017. – Volume 12, Pages 593—603
    DOI / PubMed abstract
  33. The expanding repertoire of G4 DNA structures
    Varizhuk A., Ischenko D., Tsvetkov V., Novikov R., Kulemin N., Kaluzhny D., Vlasenok M., Naumov V., Smirnov I, Pozmogova G. *
    Biochimie. – 2017. – Volume 135, April 2017, Pages 54–62
    DOI / PubMed abstract
  34. Interaction of Bacteroides fragilis toxin with outer membrane vesicles reveals new mechanism of its secretion and delivery
    Zakharzhevskaya N.B., Tsvetkov V.B., Vanyushkina A.A., Varizhuk A.M., Rakitina D.V., Podgorsky V.V., Vishnyakov I.E., Kharlampieva D.D., Manuvera V.A., Lisitsyn F.V., Gushina E.A., Lazarev V.N., Govorun V.M. *
    Frontiers in Cellular and Infection Microbiology. – 2017. – 
    DOI / PubMed abstract
  35. In Vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus
    Argentova V.V., Aliev T.K, Zarubaev V.V., Klotchenko S.A., Shtro A.A., Sergeeva M.V., Toporova V,A., Dolgikha D.A.,  Sveshnikov P.G., Vasin A.V. and Kirpichnikov M.P. *
    Molecular Biology.- 2017.-V. 51, № 6; . 804–812 
    DOI / PubMed abstract
  36. Synthesis of camphecene derivatives using click chemistry methodology and study of their antiviral activity
    Artyushin, O.I.; Sharova, E. V.; Vinogradova, N. M.; Genkina, G. K.; Moiseeva, A. A.; Klemenkova, Z. S.; Orshanskaya, Ia. R.; Shtro, A. A.; Kadyrova, R. A.; Zarubaev, V. V.; Yarovaya, O. I.; Salakhutdinov, N. F.; Brel, V. K.
    Bioorganic & Medicinal Chemistry Letters.- 2017.- Volume 27, Issue 10,  pp 2181-2184
  37. Synthesis and Antiviral Activity of Glycyrrhizic-Acid Conjugates with Aromatic Amino Acids
    Baltina, L. A., Jr.; Fairushina, A. I.; Baltina, L. A.; Eropkin, M. Yu.; Konovalova, N. I.; Petrova, P. A.; Eropkina, E. M.
    Chemistry of Natural Compounds. - 2017. - Volume 53, Issue 6, pp 1096-1100
    DOI / PubMed abstract
  38. Anti-influenza activity of monoterpene-containing substituted coumarins
    Khomenko, T. M.; Zarubaev, V. V.; Orshanskaya, Ia. R.; Kadyrova, R. A.; Sannikova, V. A.; Korchagina, D. V.; Volcho, K.P.; Salakhutdinov, N. F.
    Reviews in the Neurosciences. - 2017. - Volume 27, Issue 13, pp 2920-2925 
  39. Population immunity to influenza virus A(H1N1)pdm09, A(H3N2) and B in the adult population of the russian federation long-term research results
    Konshina, O. S.; Sominina, A. A.; Smorodintseva, E. A.; Stolyarov, K. A.; Nikonorov, I. Yu
    Infektsiya i Immunitet. - 2017. - Volume 7, Issue 1, pp 27-33 
    DOI / PubMed abstract
  40. Telocytes in the human sinoatrial nod
    Mitrofanova L.B.,  Gorshkov A.N. , Konovalov P.V. , Krylova J.S.
    J. Cell. Mol. Med.- 2017; Vol XX, No X; P. 1-13   
  41. Searching for new oligomycin A derivatives with improved selectivity against malignant cells
    Omelchuk, O.; Tsvetkov, V.; Dezhenkova, L.; Lysenkova, L.; Bekker, O.; Danilenko, V.; Shchekotikhin, A.
    FEBS Journal. - 2017. - Volume 284. - 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, pp 336
    DOI / PubMed abstract
  42. Comparison of different strategies for siRNA delivery against influenza A virus
    Petrova, A. V.; Bondarenko, A.; Timin, A.; Afanasev, M.; Sukhorukov, G.; Vasin, A.
    FEBS Journal. - 2017. - Volume 284. - 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, pp 170
    DOI / PubMed abstract
  43. Synthesis of vinyl thioethers and bis-thioethenes from calcium carbide and disulfides
    Rodygin, K. S.; Gyrdymova, Yu. V.; Zarubaev, V.V.
    Mendeleev Communications. - 2017. - Volume 27, Issue 5, pp 476-478
    DOI / PubMed abstract
  44. 6-Nitrotriazolo[1,5-alpha]pyrimidines as Promising Structures for Pharmacotherapy of Septic Conditions
    Savateev, K. V.; Ulomsky, E. N.; Fedotov, V. V.; Rusinov, V. L.; Sivak, K. V.; Lyubishin, M. M.;  Kuzmich, N. N.; Aleksandrov, A. G.
    Russian journal of Bioorganic Chemistry. - 2017. - Volume 43, Issue 4, pp 421-428
    DOI / PubMed abstract
  45. Kagocel in the therapy of influenza and acute respiratory viral infections: Data analysis and systematization from the results of preclinical and clinical trials
    Sologub, T. V.; Tsvetkov, V. V.
    Terapevticheskii Arkhiv. - 2017. - Volume 89, Issue 8, pp 113-119 
  46. Induction of fibrillogenesis of a number of biologically active peptides in the presence of  triazavirin
    Tsvetkov, V.; Protasov, A.; Gorshkov, A.; Shaldzhyan, A.; Mirgorodskaya, O.
    FEBS Journal. - 2017. - Volume 284. - 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, pp 193
    DOI / PubMed abstract

2016

  1. Interaction Of The Dye Congo Red With Fibrils Of Lysozyme, Beta2-Microglobulin And Transthyretin
    Antimonova O.I., Grudinina N.A., Egorov V.V., Polyakov D.S., Iljin V.V., Shavlovsky M.M.*
    Cell and Tissue Biology. – 2016. – Volume 10, Issue 6, pp 468–475
    DOI / PMC Abstract
  2. Biological evaluation of tetracationic compounds based on two 1,4-diazabicyclo[2.2.2]octane moieties connected by different linker
    Burakova E.A., Saranina I.V., Tikunova N.V., Nazarkina Z.K., Laktionov P.P., Karpinskaya L.A., Anikin V.B., Zarubaev V.V., Silnikov V.N.*
    Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 22, PP. 6012–6020
    DOI / PMC Abstract
  3. Characterization of oligomerization of a peptide from the ebola virus glycoprotein by small-angle neutron scattering
    Egorov V.V., Gorshkov A.N., Murugova T.N., Vasin A.V., Lebedev D.V., Isaev-Ivanov V.V., Kiselev O.I.*
    Crystallography Reports. – 2016. – Volume 61, Issue 1, pp 94–97
    DOI / PMC Abstract
  4. On the structural features of influenza A nucleoprotein particles from small-angle X-ray scattering data
    Egorov V.V., Shaldzhyan A.A., Gorshkov A.N.,  Zabrodskaya Ya.A., Lebedev D.V., Kuklin A.I., Ksenofontova O.I., Shvetsov A.V. , Vasin A.V. et al*
    Journal of Surface Investigation. – 2016. – Volume 10, Issue 2, pp 322-325
    DOI / PMC Abstract
  5. Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis
    Galochkina A.V., Anikin V.B., Babkin V.A., Ostrouhova L.A., Zarubaev V.V.*
    Archives of Virology. – 2016. – Volume 161, Issue 4, pp 929–938
    DOI / PMC Abstract
  6. Functional linkage between the transport characteristics of the MDCK1 cell monolayer and their actin cytoskeleton organization
    Gorshkov A.N., Zaitseva M.R., Snigirevskaya E.S., Komissarchik Ya.Yu.*
    Cell and Tissue Biology. – 2016. – Volume 10, Issue 2, pp 133–144
    DOI / PMC Abstract
  7. Modeling of conformational transitions of fibrillogenic peptide, homologous to beta-domain of human alpha-lactalbumin
    Kadochnikov V.V. Egorov V.V., Shvetsov A.V., Kuklin A.I., Isaev-Ivanov V.V., Lebedev D.V.*
    Crystallography Reports. – 2016. – Volume 61, Issue 1, pp 98–105
    DOI / PMC Abstract
  8. Model System for Multifunctionaldelivery Nanoplatforms Based On-Polymer Complexes Containing Silver Nanoparticles and Fluorescent Dye
    Kasyanenko N., Bakulev V., Perevyazko I., Nekrasova T., Nazarova O., Zolotova Y., Panarin E., Slita A.*
    Journal of Biotechnology. – 2016. – Volume 236, Pages 78–87
    DOI / PMC Abstract
  9. Rapid spread of influenza A(H1N1)pdm09 viruses with a new set of specific mutations in the internal genes in the beginning of 2015/2016 epidemic season in Moscow and Saint-Petersburg (Russian Federation)
    Komissarov A., Fadeev A., Petrov S., Sergeeva M., Sintsova K., Egorova A., Pisareva M., Buzitskaya Z., Musaeva T., Danilenko D., Konovalova N., Petrova P., Stolyarov K., Smorodintseva E., Burtseva E., Krasnoslobodtsev K., Kirillova E., Karpova L., Eropkin M., Sominina A., Grudinin M.*
    Influenza and Other Respiratory Viruses. – 2016. – Volume 10, Issue 4, Pages 247–253
    DOI / PMC Abstract
  10. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season
    López-Labrador FX, Natividad-Sancho A, Pisareva M, Komissarov A, Salvatierra K, Fadeev A, Moya A, Grudinin M, Díez-Domingo J, Afanasieva O, Konovalova N, Sominina A, Puig-Barberà J.*
    Journal of Clinical Virology. – 2016. – Volume 84, November 2016, Pages 32–38
    DOI / PMC Abstract
  11. High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin
    Mardanova ES, Kotlyarov RY, Kuprianov VV, Stepanova LA, Tsybalova LM, Lomonossoff GP, Ravin NV*
    Bioengineered. – 2016. – Volume 7, Issue 1, pp 28–32
    DOI / PMC Abstract
  12. Designing anti-influenza vaccines in line with the population’s genetic profile
    Onishchenko G.G., Kiselev O.I.*
    Herald of the Russian Academy of Sciences. – 2016. – Vol. 86. № 3. pp 197-205
    DOI / PMC Abstract
  13. Anti-influenza activity of monoterpene-derived substituted hexahydro-2H-chromenes
    Patrusheva OS, Zarubaev VV, Shtro AA, Orshanskaya YR, Boldyrev SA, Korchagina DV, Volcho KP, Salakhutdinov NF*
    Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 21, Pages 5158–5161
    DOI / PMC Abstract
  14. Development of a multiplex quantitative PCR assay for the analysis of human cytokine gene expression in influenza A virus-infected cells
    Plotnikova M.A., Klotchenko S.A., Vasin A.V.
    Journal of Immunological Methods. – 2016. – Volume 430, Pages 51–55
    DOI / PMC Abstract
  15. Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the global influenza hospital surveillance network
    Puig-Barberà J., Burtseva E., Yu H., Cowling B.J., Badur S., Kyncl J., Sominina A., Afanasieva O., Afanasieva V., Ciblak M.A., Aktas F., Belenguer-Varea Á., Borekci S., Boza F., Buzitskaya Z., Caetano B., Cai J., Çakir B., Carballido-Fernández M. et al.*
    BMC Public Health. – 2016. – Volume 16, (Suppl 1):757
    DOI / PMC Abstract
  16. Epidemiology of hospital admissions with influenza during the 2013/2014 northern hemisphere influenza season: results from the global influenza hospital surveillance network
    Puig-Barberà J., Natividad-Sancho A., Mira-Iglesias A., López-Labrador X., Trushakova S., Kisteneva L., Burtseva E., Garina E., Kolobukhina L., Krasnoslobotsev K., Merkulova L., Mukasheva E., Vartanyan R., Sominina A., Pisareva M., Stolyarov K., Afanasieva V., Buzitskaya Z., Fadeev A., Smorodintseva E. et al.*
    PLoS ONE. – 2016. – May 19;11(5):e0154970
    DOI / PMC Abstract
  17. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
    Rudenko L., Isakova-Sivak I., Naykhin A.,  Kiseleva I., Stukova M.,  Erofeeva M.,  Korenkov D., Matyushenko V., Sparrow E., Kieny M.P.*
    The Lancet Infectious Diseases. – 2016. – Volume 16, Issue 3, Pages 303–310
    DOI / PMC Abstract
  18. Derivatives of usnic acid inhibit broad range of influenza viruses and protect mice from lethal influenza infection
    Shtro A.A., Zarubaev V.V., Luzina O.A., Sokolov D.N., Salakhutdinov N.F.*
    Antiviral Chemistry and Chemotherapy. – 2016. – vol. 24, 3-4: pp. 92-98
    DOI / PMC Abstract
  19. Efficiency of Canephron N in complex treatment of experimental heymann glomerulonephritis
    Sivak K.V., Lesiovskaya E.E., Stosman K.I., Savateeva-Lubimova T.N.*
    Clinical Phytoscience. – 2016. – Volume 2, Issue 1
    DOI / PMC Abstract
  20. Adenosine A2A receptor as a drug target for treatment of sepsis
    Sivak KV, Vasin AV, Egorov VV, Tsevtkov VB, Kuzmich NN, Savina VA, Kiselev OI*
    Molecular Biology. – 2016. – Volume 50, Issue 2, pp 200–212
    DOI / PMC Abstract
  21. Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1
    Sokolova AS, Yarovaya I, Shernyukov V, Baev DS, Shtro AA, Zarubaev VV, Salakhutdinov NF*
    European Journal of Medicinal Chemistry. – 2016. – Available online 19 October 2016, In Press
    DOI / PMC Abstract
  22. Influence of single amino acid substitutions in the hemagglutinin on the antigenic and receptor-binding properties of influenza virus B/Florida/04/2006 of Yamagata-like evolutionary lineage
    Sorokin Evgeniy V., Tsareva Tatyana R., Sominina Anna A., Pisareva Maria M., Komissarov Andrey B., Kosheleva nna .
    Microbiology Independent Research Journal . – 2016. – Volume 3, Number 1, pp 56-60
    DOI / PMC Abstract
  23. A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity
    Stepanova L.A., M. V. Sergeeva, M. A. Shuklina, A. A. Shaldzhyan, M. V. Potapchuk, A. V. Korotkov, L. M. Tsybalova
    Acta Naturae. – 2016. – Vol. 8, № 2(29)
    DOI / PMC Abstract
  24. Interaction between cationic agents and small interfering RNA and DNA molecules
    Unksov I.N., Slita A.V., Petrova A.V., Pereviazko I., Bakulev V.M., Rolich V.I., Bondarenko A.B., Kasyanenko N.A.*
    Journal of Physics: Conference Series. – 2016. – Volume 769, Number 1
    DOI / PMC Abstract
  25. The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure
    Vasin A.V., Petrova A.V., Egorov V.V., Plotnikova M.A., Klotchenko S.A., Karpenko M.N., Kiselev O.I.*
    BMC Research Notes. – 2016. – (9):(279)
    DOI / PMC Abstract
  26. Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: an in vitro study
    Zarubaev VV., Morkovnik AS, Divaeva LN, Karpinskaya LA, Borodkin GS*
    Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 22, Pages 5796–5803
    DOI / PMC Abstract
  27. Main Aetiological Features of Acute Respiratory Viral Diseases in Young People of Draft Age and Conscripts During the 2013-2014 Epidemic Season
    Zhdanov K., Lvov N., Maltsev O., Peredelsky E. and Pisareva M.*
    International Review of the Armed Forces Medical Services. – 2016. – V. 89/2. - 58-63
    DOI / PMC Abstract

2015

  1. Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents
    Kiselev O.I., Vasin A.V., Deeva E.G., Sivak K.V., Egorov V.V., Tsvetkov V.B., Egorov A.Y., Romanovskaya-Romanko E.A., Stepanova L.A., Komissarov A.B., Tsybalova L.M., Ignatjev G.M., Shevyryova M.P.*
    Molecular Biology [Moscow].  – 2015. – Vol.49, № 4. – P. 480-493. [English version]
  2. Peptide-induced amyloid conformational transitions in proteins
    Egorov  V., Grudinina  N., Vasin A., Lebedev D.
    International Journal of Peptides. – 9/2015 (2015). Article ID 723186, 5 pp.
  3. Identification of genetic determinants of influenza A virus resistance to adamantanes and neuraminidase inhibitors using biological microarray
    Heydarov R.N., Fesenko E.E., Shaskolskiy B.L., Titov S.V., Dementieva E.I., Zasedatelev A.S., Mikhailovich V.M., Klotchenko S.A., Vasin A.V., Kiselev O.I.*
    Doklady. Biochemistry and Biophysics. – 2015. – Vol.460, № 1. – P. 4-8. [English version]
    Epub 2015 Mar 13.
    doi: 10.1134/S1607672915010032.
  4. Nucleophilic substitution of nitro group in nitrotriazolotriazines as a model of potential interaction with cysteine-containing proteins
    Rusinov V.L., Sapozhnikova I.M., Ulomskii E.N., Medvedeva N.R., Egorov V.V., Kiselev O.I., Deeva E.G., Vasin A.V., Chupakhin O.N.*
    Chemistry of Heterocyclic Compounds. – 2015. – Vol. 51, Issue 3. – P.275–280. [English version]
    Epub 2015 Apr 16.
  5. Regulatory role of small nucleolar RNAs in human diseases
    Stepanov G.A., Filippova J.A., Kuligina E.V., Richter V.A., Semenov D.V., Komissarov A.B., Tang T.H.*
    Biomed Research International. – 2015. – ID 206849, 10 pp.
  6. Synthesis  and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments
    Matusevich O.V., Egorov V.V., Gluzdikov I.A., Titov M.I., Zarubaev V.V., Shtro A.A., Slita A.V., Dukov M.I., Shurygina A.-P., Smirnova T.D., Kudryavtsev I.V., Vasin A.V., Kiselev O.I.*
    Antiviral Research. – 2015. – Vol. 113. – P.4-10.
    doi: 10.1016/j.antiviral.2014.10.015. Epub 2014 Nov 12.
  7. Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo
    Zarubaev V.V., Garshinina A.V., Tretiak T.S., Fedorova V.A., Shtro A.A., Sokolova A.S., Yarovaya O.I., Salakhutdinov N.F.
    Antiviral Research. – 2015. – Vol. 120. – P.126-133.
    doi: 10.1016/j.antiviral.2015.06.004. Epub 2015 Jun 10.
  8. Discovery of a new class of antiviral compounds: Camphor imine derivatives
    Sokolova A.S. , Yarovaya O.I., Shernyukov A.V., Gatilov Y.V., Razumova Y.V., Zarubaev V.V.,  Tretiak T.S.,  Pokrovsky A.G., Kiselev O.I., Salakhutdinov N.F.*
    European Journal of Medical Chemistry. – 2015. – Vol.105. – P.263-273.
    doi: 10.1016/j.ejmech.2015.10.010. Epub 2015 Oct 22.
  9. Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors
    Baltina L.A. Jr., Zarubaev V.V., Baltina L.A., Orshanskaya I.A., Fairushina A.I., Kiselev O.I., Yunusov M.S.*
    Bioorganic & Medicinal Chemistry Letters. – 2015. – Vol. 25, № 8. – P.1742-1746.
    doi: 10.1016/j.bmcl.2015.02.074. Epub 2015 Mar 7.
  10. Synthesis and antiviral activity of quercetin brominated derivatives
    Karimova E., Baltina L., Spirikhin L., Gabbasov T., Orshanskaya Y., Zarubaev V.
    Natural Product Communications. – 2015.Vol. 10, № 9. – P.1565-1568.
  11. New  carbocyclic N6-substituted adenine and pyrimidine nucleoside analogues with a bicyclo[2.2.1]heptane fragment as sugar moiety; synthesis, antiviral, anticancer activity and X-ray crystallography
    Tănase C.I., Drăghici C., Cojocaru A., Galochkina A.V., Orshanskaya J.R., Zarubaev V.V., Shova S., Enache C., Maganu M.*
    Bioorganic & Medicinal Chemistry. – 2015. – Vol. 23, № 19. – P.6346-6354.
    doi: 10.1016/j.bmc.2015.08.033. Epub 2015 Sep 1.
  12. Search for antiviral agents among quinopimaric acid scaffold derivatives
    Vafina G.F.,  Uzbekov A.R., Zarubaev V.V., Karpinskaya L.A., Shtro A. A., Yunusov M.S.
    Chemistry of Natural Compounds. – 2015. – Vol.51, № 1. – P.103-107. [English version]
  13. Activity of Thermopsis schischkinii alkaloids against influenza A(H1N1)pdm09 virus
    Tsypysheva I.P., Galkin E.G., Baikova I.P., Fedorov N.I., Petrova P.R.,.Orshanskaya Ya.R., Fedorova V.A., Zarubaev V.V.
    Chemistry of Natural Compounds. – 2015. – Vol.51, № 5. – P.1003-1005.
    Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin
    Stepanova L.A., Kotlyarov R.Y., Kovaleva A.A., Potapchuk M.V., Korotkov A.V., Sergeeva M.V., Kasianenko M.A., Kuprianov V.V., Ravin N.V., Tsybalova L.M., Skryabin K.G., Kiselev O.I.*
    PLoS One. – 2015. – Vol. 10, № 3. – e0119520.
    doi: 10.1371/journal.pone.0119520
  14. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
    Mardanova E.S., Kotlyarov R.Y., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Lomonosoff G.P., Ravin N.V.
    BMC Biotechnology. – 2015. – Vol. 15. – 42.
    doi: 10.1186/s12896-015-0164-6.
  15. High immunogenicity of plant-produced influenza based on the M2e peptide fused to flagellin
    Mardanova E.S., Kotlyarov R.Y., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Lomonosoff G.P., Ravin N.V.*
    Bioengineered. – 2015. – Dec 28:0. [Epub ahead of print]
    doi: 10.1186/s12896-015-0164-6.
  16. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency
    Ravin N.V., Blokhina E.A., Kuprianov V.V., Stepanova L.A., Shaldjan A.A., Kovaleva A.A., Tsybalova L.M., Skryabin K.G.*
    Vaccine. – 2015. – Vol. 33, № 29. - P. 3392–3397.
    doi: 10.1016/j.vaccine.2015.04.066. Epub 2015 Apr 29.
  17. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e
    Tsybalova L.M., Stepanova L.A., Kuprianov V.V., Blokhina E.A., Potapchuk M.V., Korotkov A.V., Gorshkov A.N., Kasyanenko M.A., Ravin N.V., Kiselev O.I.*
    Vaccine. – 2015. – Vol. 33, № 29. - P. 3398–3406.
    doi: 10.1016/j.vaccine.2015.04.073. Epub 2015 May 11.
  18. Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double- blind phase 1 study
    Rudenko L., Kiseleva I., Stukova M.,  Erofeeva M.,  Naykhin A.,  Donina S.,  Larionova N., Pisareva M., Krivitskaya V., Flores J.; Russian LAIV Trial Study group*
    Vaccine. – 2015. – Vol. 33, № 39. – P.5110-5117. -
    doi: 10.1016/j.vaccine.2015.09.050. Epub 2015 Oct 2.
  19. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses
    Kiseleva I., Dubrovina I.,  Fedorova E., Larionova N., Isakova-Sivak I., Bazhenova E., Pisareva M., Kuznetsova V., Flores J., Rudenko L.*
    Vaccine. – 2015. – Vol. 33, № 49. – P.7008-7014.
    doi: 10.1016/j.vaccine.2015.09.050. Epub 2015 Oct 2.
  20. H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
    Isakova-Sivak I., Stukova M.,  Erofeeva M.,  Naykhin A.,  Donina S.,  Petukhova G.,  Kuznetsova V.,  Kiseleva I.,  Smolonogina T., Dubrovina I.,  Pisareva M.,  Nikiforova A.,  Power M., Flores J., Rudenko L.*
    Human Vaccines & Immunotherapeutics. – 2015. – Vol. 11, № 4. – P.970- 982. -
    doi: 10.1080/21645515.2015.1010859.
  21. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
    Rudenko L., Naykhin A.,  Donina S.,  Korenkov D., Petukhova G.,  Isakova-Sivak I., Losev I., Stukova M.,  Erofeeva M.,  Nikiforova A.,  Power M., Flores J.*
    Human Vaccines & Immunotherapeutics. – 2015. – Vol. 11, № 12. – P.2839-2848.
    doi: 10.1080/21645515.2015.1069931.
  22. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
    Rudenko L., Isakova- Sivak I., Naykhin A.,  Kiseleva I., Stukova M.,  Erofeeva M.,  Korenkov D., Matyushenko V., Sparrow E., Kieny M.P.*
    The Lancet. Infectious Diseases. – 2015. – Dec. 7. Pii: S1473-3099 (15)00378-3.
    doi: 10.1016/S1473-3099(15)00378-3. [Epub ahead of print].
  23. A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice
    Kittel C., Wressnigg N., Shurygina A.P., Wolschek M., Stukova M.,  Romanovskaya-Romanko E., Romanova J., Kiselev O., Muster T., Egorov A.
    Archives of Virology.2015. – Vol. 160, № 10. – P.2525- 2534.
    doi: 10.1007/s00705-015-2525-9. Epub 2015 Jul 28.
  24. Mutations in human genes that increase the risk for severe influenza infection
    Kiselev O. I., Komissarov A. B., Konshina O.S , Dmitrieva M.N., Deyeva E.G., Sologub T.V., Pokrovskiy V.I.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
  25. Changes in the antigenic and genetic structure of influenza viruses: analysis of surveillance data of influenza A and B in Russia in 2006-2013
    Grudinin M.P., Pisareva M.M., Komissarov A.B., Kosheleva A.A., Buzitskaya J.V., Stukova M.A., Prokopetz A.V., Danilenko D.M., Konovalova N.I., Lobova T.G., Sominina A.A., Kiselev O.I.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
  26. Two years of experience in hospital surveillance for the severe influenza like illnesses in St. Petersburg: etiology, clinical characterization of diseases, antigenic and genetic properties of isolated influenza viruses
    Sominina A.A., Pisareva M. M., Grudinin M.P., Eropkin M.Yu., Konovalova N.I, Sukhovetskaya V.F., Afanasieva O.I., Voloshuk L.V., Komissarov A.B., Buzitskaya Z.V., Fadeev A.V., Stolyarov K.A., Smorodintseva E.A., Afanasieva V.S., Yanina M.A., Gonchar V.V., Osidak L.V., Go A.A.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
  27. The Global Influenza Hospital Surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza
    Puig- Barberà  J., Tormos A.,Trushakova  S., Sominina  A., Pisareva M. et al.
    Influenza and Other Respiratory Viruses. – 2015.  – Vol. 9, Issue 6. – P.277–286.
    doi: 10.1111/irv.12335
  28. Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region – an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases
    Meerhoff T.J., Simaku A, Ulqinaku D, Torosyan L, Gribkova N, Shimanovich V, Chakhunashvili G, Karseladze I, Yesmagambetova A, Kuatbayeva A, Nurmatov Z, Otorbaeva D, Lupulescu E, Popovici O, Smorodintseva E, Sominina A, Holubka O, Onyshchenko O, Brown CS, Gross D.*
    BMC Infectious Diseases. – 2015. – Vol. 15. – 1.
    doi: 10.1186/s12879- 014-0722-x.
  29. Nanosolutions
    Lyubchik S., Lyubchik A., Makarova T., Eropkin M.
    International Innovation. – 2015. – Issue 187. - P. 31-33.
  30. Physicochemical molecular, and biological properties of complexes formed between aminoglycoside antibiotics and some anionic copolymers of acrylic series: Part II
    Tarabukina E.B., Solovskii M.V., Pautov V.D., Amirova A.I., Zahkarova N.V., Smirnova M.Y., Anan’eva T.D., Imanbaev R.T., Eropkin M.Y., Eropkina E.M.*
    Journal of Bioactive and Compatible Polymers: Biomedical Applications. – 2015. – Vol.30, № 6. – P.571-583.
    Epub July 6, 2015 doi:10.1177/0883911515592258.

Books and proceedings:

Abstracts of the 18th Annual Meeting of European Society for Clinical Virology, 9th–12th September 2015, Edinburgh // Journal of Clinical Virology. – Vol.70, Suppl.1.

  • Effect of single amino acid substitutions in the hemagglutinin on the receptor-binding properties of influenza B viruses
    Sorokin E., Tsareva T., Sominina A., Pisareva M., Komissarov A., Kosheleva A. – P.S29 (Abstr. № 1502).
  • Influenza in Russia in the season 2014–2015: Epidemiology and antigenic properties of viruses
    Eropkin M., Karpova. L., Konovalova N., Lobova T., Petrova P., Eropkina E., Schekanova S., Sominina A. – P.S30 (Abstr. № 1503).
  • Virus etiology of SARI cases and protective role of influenza vaccination determined in sentinel surveillance system
    Smorodintseva E., Sominina A., Stolyarov K., Sysoeva T. – P.S30 (Abstr. № 1504).

2014

Research papers:

  1. Molecular mechanisms enhancing the proteome of influenza A viruses: An overview of recently discovered proteins
    Vasin A.V., Temkina O.A.,  Egorov V.V., Klotchenko S.A., Plotnikova M.A., Kiselev O.I.
    Virus Research. – 2014. – Vol. 185. – P.53-63.
    doi: 10.1016/j.virusres.2014.03.015. Epub 2014 Mar 24.
  2. Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector
    Kuznetsova I., Shurygina A.P., Wolf B., Wolschek M., Enzmann F., Sansyzbay A., Khairullin B., Sandybayev N., Stukova M., Kiselev O., Egorov A., Bergmann M.*
    Journal of General Virology. – 2014. – Vol.95, pt.2. – P.337-349.
    doi: 10.1099/vir.0.056036-0. Epub 2013 Nov.12.
  3. A conservative mutant of a proteolytic fragment produced during fibril formation enhances fibrillogenesis
    Egorov V.V., Lebedev D.V., Shaldzhyan A.A., Sirotkin A.K., Gorshkov A.N., Mirgorodskaya O.A., Grudinina N.A., Vasin A.V., Shavlovsky M.M. *
    Prion. – 2014. – Vol.8, 5. – P.369-373.
    doi: 10.4161/19336896.2014.983745.
  4. Comparative evaluation of effectiveness of IAVchip DNA microarray in influenza A diagnosis
    Sultankulova K.T., Chervyakova O.V., Kozhabergenov N.S., Shorayeva K.A., Strochkov V.M., Orynbaev M.B., Sandybayev N.T., Sansyzbay A.R., Vasin A.V.*
    Scientific World Journal. – 2014. – (2014). – ID 620580. – 11 pp.
    doi: 10.1155/2014/620580. Epub 2014 Nov.23.
  5. The use of inducers of apoptosis in treatment of experimental influenza infection and prevention of chronic postinfluenza lung lesions
    Zarubaev V. V., Tribulovich V. G., Belyaevskaya S. V.,  Barlev N.A.*
    Cell and Tissue Biology. – 2014. – Vol.8, Issue 4. – P.344-351.
    (Original version: Tsitologiya. – 2014. – Vol.56, 3. – P.241-247.)
  6. Camphor-based symmetric diimines as inhibitors of influenza virus reproduction
    Sokolova A.S. , Yarovaya O.I., Korchagina D.V.,  Zarubaev V.V.,  Tretiak T.S.,  Anfimov P.M. , Kiselev O.I., Salakhutdinov N.F. *
    Bioorganic and Medical Chemistry. – 2014. – Vol.22, Issue 7. – P.2141-2148.
    doi: 10.1016/j.bmc.2014.02.038. Epub 2014 Mar 1.
  7. Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus
    Shtro A.A., Zarubaev V.V., Luzina O.A., Sokolov D.N., Kiselev O.I., Salakhutdinov N.F.*
    Bioorganic and Medical Chemistry. – 2014. – Vol.22, Issue 24. – P.6826-6836.
    doi: 10.1016/j.bmc.2014.10.033. Epub 2014 Oct 31.
  8. Synthesis and antiviral activity of bis-spirocyclic derivatives of rhodanine
    Kurbatov S.V., Zarubaev V.V., Karpinskaya L.A., Shvets A.A., Kletsky M.E., Burov O.N., Morozov P.G., Kiselev O.I., Minkin V.I. *
    Russian Chemical Bulletin. – 2014. – Vol.63, Issue 5. – P.1130-1136.
    (Original version: Izvestiya Akademii Nauk.Ser. Khimicheskaya – 2014. – 5. – P.1130-1136.)
  9. New amino-acid conjugates of glycyrrhizic acid
    Baltina L.A. Jr., Stolyarova O.V., Baltina L.A., Kondratenko R.M., Fedorova V.A., Orshanskaya Ya.A., Zarubaev V.V.*
    Chemistry of Natural Compounds. – 2014. – Vol.50, Issue 2. – P.317-320.
  10. Synthesis and antiviral activity of amino-acid conjugates of glycyrrhetic acid
    Baltina L.A. Jr., Khudobko M.V., Mikhailova L.R., Baltina L.A., Fedorova V.A., Orshanskaya Ya.A., Zarubaev V.V., Kiselev O.I.*
    Chemistry of Natural Compounds. – 2014. – Vol.50, Issue 3. – P.473-477.
  11. Porous silicon and its applications in biology and medicine
    Ksenofontova O. I., Vasin A.V., Egorov V.V., Kiselev. O.I., Bobyl A.V., Soldatenkov F.Yu., Terukov E.I., Ulin V.P., Ulin N.V.*
    Technical Physics. The Russian Journal of Applied Physics.  – 2014. – Vol. 59, Issue 1. – P. 66-77.
    (Original version: Zhurnal Tekhnicheskoi Fiziki, – 2014. – Vol.84, 1. – P.67-78.)
  12. Photodynamic inactivation of enveloped virus in protein plasma preparations by solid-phase fullerene-based photosensitizer
    Belousova I.M.,  Kislyakov I.M., Muraviova T.D., Starodubtsev A.M., Kris’ko T.K. , Selivanov E.A. , Sivakova N.P., Golovanova I.S., Volkova S.D., Shtro A.A.,  Zarubaev V.V. *
    Photodiagnosis and Photodynamic Therapy. –  2014. – Vol.11, Issue 2. – P.165-170.
    doi:10.1016/j.pdpdt.2014.02.009
  13. Recombinant strain A/HK/Otar/6:2/2010 (H3N8) for development of a live intranasal equine influenza vaccine
    Chervyakova O.V., Strochkov V.M., Tailakova E.T., Sultankulova K.T., Sandybayev N.T., Sansyzbay A.R., Gorev N.A., Sergeeva M.V., Potapchuk M.V., Repko I.A., Tsybalova L.M., Kiselev O.I.*
    Journal of Equine Veterinary Science. – 2014. – Vol.34, Issue 6. – P.749-758.
  14. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo–controlled, randomized double–blind phase I study of live attenuated H7N3 influenza vaccine
    Rudenko L., Kiseleva I., Naykhin A., Erofeeva M., Stukova M., Donina S., Petukhova G., Pisareva M., Krivitskaya V., Grudinin M., Buzitskaya Zh., Isakova-Sivak I., Kuznetsova S., Larionova N.,  Desheva J., Dubrovina I., Nikiforova A., Victor J., Neuzil K., Flores J., Tsvetnitsky V., Kiselev O.*
    PLoS One. – 2014. – Vol. 9, 2. – e87962.
    doi: 10.1371/journal.pone.0087962
  15. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network
    Puig-Barberà J., Natividad-Sancho A., Launay O., Burtseva E., Ciblak M.A.,  Tormos A., Buigues-Vila A., Martinez-Ubeda S., Sominina A.; GIHSN Group*
    PLoS One. – 2014. – Vol. 9, 6. – e100497. (Correction: PLoS One. – 2014. – Vol. 9, 9. – e107849.)
    doi: 10.1371/journal.pone.0100497.
  16. Evidence of specialized tissue in human interatrial septum: histological, immunohistochemical and ultrastructural findings
    Mitrofanova L.B., Gorshkov A.N., Lebedev D.S., Mikhaylov E.N.*
    PLoS One. – 2014. – Vol. 9, 11. – e113343.
    doi: 10.1371/journal.pone.0113343.
  17. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season
    Puig-Barberà J., Tormos A.,  Sominina A., Burtseva E., Launay O., Ciblak M.A., Natividad-Sancho A., Buigues-Vila A., Martinez-Ubeda S., Mahe C.; GIHSN Group*
    BMC Public Health. – 2014. – Vol. 14. – 564.
    doi: 10.1186/1471-2458-14-564.
  18. Vitreous films of Ga6Ge17S43 composition as a biochip substrate
    Vasil’eva A.S., Borisov E.N., Klotchenko S.A., Tver’yanovich A.S., Tver’yanovich Yu.S.*
    Glass Physics and Chemistry. – 2014. – Vol.40, Issue 4. – P.467-469.
    (Original version: Fizika i Khimiya Stekla. – 2014. – Vol.40, 4. – P.615-618.)
  19. As39S6 films as protein-selective two-dimensional arrays for biochips
    Vasil’eva A.S., Belykh A.V., Klotchenko S.A., Tver’yanovich A.S., Tver’yanovich Yu.S.*
    Glass Physics and Chemistry. – 2014. – Vol.40, Issue 4. – P.470-471.
    (Original version: Fizika i Khimiya Stekla. – 2014. – Vol.40, 4. – P.619-621.)
  20. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines
    Nakowitsch S., Waltenberger A.M., Wressnigg N., Ferstl N., Triendl A., Kiefmann B., Montomoli E., Lapini G., Sergeeva M.,  Muster T., Romanova J.R.
    Biotechnology Journal. – 2014. – Vol.9, Issue 3. – P. 405-414.

Books and proceedings:

The Fifth ESWI Influenza Conference, Riga, Latvia, September 14–17, 2014:

  • Comparative Analysis of MariPOC System And RRT-PCR in Detection of Influenza a Virus in Clinical Samples
    Petrova, Ekateria; Krivitskaya, Vera; Pisareva, Maria; Buzitskaya, Zhanna; Sukhovetskaya, Vera; Danilenko, Daria; Suddenkova, Polina; Sominina, Anna A.
    SPA1P06
  • Epitope Mapping of the Hemagglutinin Molecule of Influenza B/Yamagata And B/Victoria Lineage Viruses Using Monoclonal Antibodies
    Sorokin, Evgenii; Tsareva, Tatiana; Sominina, Anna A.; Pisareva, Maria; Komissarov, Andrei; Kosheleva, Anna
    SPB5P08
  • Host-specific Distribution of (+)-RNA Secondary Structures in Segment 8 of Influenza A Viruses
    Vasin, Andrey; Petrova, Alexandra; Plotnikova, Marina; Klotchenko, Sergey; Egorov, Vladimir; Kiselev, Oleg
    SPB5P02
  • Influenza Epidemic Season 2013-2014 in Russia: Characteristics of Isolated Strains
    Eropkin, Mikhail; Danilenko, Daria; Konovalova, Nadejda; Komissarov, Andrey; Pisareva, Maria; Grudinin, Mikhail; Lobova, Tamara; Schekanova, Svetlana; Kornilova, Ekaterina; Eropkina, Elena; Suddenkova, Polina
    SPA2P04
  • Some Approaches to Prediction of Seasonal Influenza Epidemic Burden
    Sominina, Anna A.; Karpova, Ludmila; Smorodintseva, Elizaveta; Grudinin, Mikhail; Pisareva, Maria; Komissarov, Andrei; Eropkin, Mikhail; Konovalova, Nadejda; Danilenko, Daria
    SPA2P12
  • Molecular Peculiarities of Influenza A and B Viruses Circulating in Russia During Two Epidemic Seasons in 2012-2014
    Komissarov, Andrey; Kosheleva, Anna; Fadeev, Artem; Elpaeva, Ekaterina; Mikhailova, Maria; Pisareva, Maria; Buzitskaya, Janna; Stukova, Marina; Danilenko, Daria; Konovalova, Nadejda; Eropkin, Mikhail; Grudinin, Mikhail
    SPB5P05
  • Hospitalizations with Influenza in the Northern Hemisphere 2013-2014 Influenza Season. Results from the Global Influenza Hospital Surveillance Network
    Puig-Barberà, Joan; Tormos, Anita Marie Catherine; Sominina, Anna; Ciblak, Meral; Mira-Iglesias, Ainara; Natividad-Sancho, Angels; Buigues-Vila, Amparo; Burtseva, Elena
    SPA1P03

4th International Influenza Meeting, Muenster, Germany, September 21–23, 2014:

  • Infection of primary endometrium cells with influenza A(3N2) virus can cause their functional dysregulation
    Danilenko D.M., Smirnova T.D., Pisareva M.M., Durnova A.O., Kadirova R.A., Smirnova S.S.*
    Abstr.P15. – P.62.
  • Antiviral and cytoprotective activity of Influcid® in cell cultures model systems
    Eropkin M., Eropkina E., Bryazhikova T.
    Abstr.P23. – P.70.
  • Influenza surveillance in swine in North-Western region of Russia
    Komissarov A.B., Konovalova N.I., Fadeev A.V., Sintsova K.S., Palaziuk S.V., Aliev A.S., Danilenko D.M., Eropkin M.Yu., Grudinin M.P.*
    Abstr.P51. – P.98.
  • A new aspect of influenza virus pathogenesis
    Azarenok A.A., Prochukhanova A.R., Ilynskaya E.V., Zenin V.V., Lublinskaya O.G., Eropkina E.M., Zhilinskaya I.N.
    Abstr.P74. – P.121.
  • Immunogenicity graphs as a method of assessment and comparison of viruses in the contemporary influenza vaccine
    Voytsehovskaya E.M., Vasilyeva A.A., Kuznetsova E.V., Vakin V.S., Sominina A.A.
    Abstr.P108. – P.155.

17th Annual Meeting of the European Society for Clinical Virology (ESCV), Prague, Czech Republic, September 27–October 1, 2014:

  • A novel automated mariPOC® detection test detects well current and emerging inluenza A virus subtypes
    Koskinen J., Sominina A.A., Krivitskaya V. Z., Voycekhovskaya E.V., Toivola H., Koskinen J.O.*
    Abstr.P01. – ID 63.

2013

Research papers:

  1. Influenza surveillance in Russia based on epidemiological and laboratory data for the period from 2005 to 2012
    Sominina A., Burtseva E., Eropkin M., Karpova L., Zarubaev V., Smorodintseva E., Konovalova N., Danilenko D., Prokopetz A., Grudinin M., Pisareva M., Anfimov P., Stolyarov K., Kiselev O., Shevchenko E., Ivanova V., Trushakova S., Breslav N., Lvov D., Klimov A., Moen A., Cox N. *
    American Journal of Infectious Diseases. – 2013. – Vol.9, № 3. – P.77-93
  2. Transmission studies resume for avian flu
    Fouchier R.A., Garcia-Sastre A., Kawaoka Y., …… Kiselev O.I., et al.*
    Science. – 2013. – Vol.339, № 6119. – P.520-521.
    doi: 10.1126/science.1235140. Epub 2013 Jun 23.
  3. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution
    Koel B.F., Burke D.F., Bestebroer T.M., ………. Eropkin M.Y., et al.*
    Science. – 2013. – Vol.342, № 6161. – P.976-979.
    doi: 10.1126/science.1244730. Epub 2013 Jun 23.
    Structural features of the peptide homologous to 6-25 fragment of influenza A PB1 Protein
    Egorov V.V., Matusevich O.V., Shaldzhyan A.A., Skvortsov A.N., Zabrodskaya Ya.A., Garmay Yu.P., Landa S.B., Lebedev D.V., Zarubayev V.V., Sirotkin A.K., Vasin A.V., Kiselev O.I. *
    International Journal of Peptides. – 2013. – Vol. 2013. – ID 370832. – 5 pp. http://dx.doi.org/10.1155/2013/370832
  4. Amyloidogenic peptide homologous to fragment 129-148 of human myocilin
    Egorov V.V., Grudinina N.A., Lebedev D.V., Shaldzhyan A.A., Slita A.V., Sirotkin A.K., Vasin A.V., Shavlovsky M.M.*
    Prion. – 2013. – Vol. 7, № 3. – P.248-252.
    doi: 10.4161/pri.24239.
  5. Magnetic labeling of proteins for atomic force microscopy
    Egorov V.V., Zabrodskaya Y.A., Kalinin A.S., Lebedev D.V., Grudinina N.A., Vasin A.V., Kolikov V.A., Klotchenko S.A., Shawlovsky M.M., Rutberg P.G. *
    Doklady. Biochemistry and Biophysics. – 2013. – Vol.448, Issue 1. – P.33-35.
    doi: 10.1134/S1607672913010080. Epub 2013 Mar 13.
    (Original version: Doklady Akademii Nauk. – 2013. – Vol.448, № 4. – P.477-479.)
  6. An inactivated adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans
    Sansyzbay A.R., Erofeeva M.K., Khairullin B.M., Sandybaev N.T., Kydyrbaev Z.K., Mamadaliyev  S.M., Kassenov M.M., Sergeeva M.V., Romanova J.R., Krivitskaya V.Z., Kiselev O.I., Stukova M.A. *
    Clinical and Vaccine Immunology. – 2013. – Vol.20, № 8. – P.1314-1319.
    doi: 10.1128/CVI.00096. Epub 2013 Jun 26.
  7. The use of transient expression systems for the rapid production of virus-like particles in plants
    Thuenemann E.C., Lenzi P., Love A.J., Taliansky M., Bécares M., Zuñiga S., Enjuanes L., Zahmanova G.G., Minkov I.N., Matić S., Noris E., Meyers A., Hattingh A., Rybicki E.P., Kiselev O.I., Ravin N.V.*
    Current Pharmaceutical Design. – 2013. – Vol.19, Issue 31. – P.5564-5573. [Review.]
  8. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by tobacco mosaic virus-based vectors
    Petukhova N.V., Gasanova T.V., Stepanova L.A., Rusova O.A., Potapchuk M.V., Korotkov A.V., Skurat E.V., Tsybalova L.M., Kiselev O.I., Ivanov P.A., Atabekov J.G.*
    Current Pharmaceutical Design. – 2013. – Vol.19, Issue 31. – P.5587-5600. doi:10.2174/13816128113199990337
  9. Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of influenza A virus
    Dukhovlinov I., Al-Shekhadat R., Fedorova E., Stepanova L., Potapchuk M., Repko I., Rusova O., Orlov A., Tsybalova L., Kiselev O.
    Medical Science Monitor Basic Research. – 2013. – Vol.19. – P.221-227.
    doi:10.12659/MSMBR.884002
  10. Synthesis of new compounds combining adamantanamine and monoterpene fragments and their antiviral activity against influenza virus A(H1N1)pdm09
    Teplov G.V., Suslov E.V., Zarubaev V.V., Shtro A.A., Karpinskaya L.A., Rogachev A.D., Korchagina D.V.,
    Volcho K.P., Salakhutdinov N.F., Kiselev O.I.*
    Letters in Drug Design & Discovery. – 2013. – Vol. 10, № 6. –  P.477-485.
  11. New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity
    Sokolova A.S., Yarovaya C.O., Shernyukov C.A., Pokrovsky C.E., Pokrovsky C.A., Lavrinenko V.A., Zarubaev V.V., Tretiak T.S., Anfimov P.M., Kiselev O.I., Beklemishev A.B., Salakhutdinov N.F.
    Bioorganic and Medicinal Chemistry. – 2013. – Vol.21, Issue 21. – P.6690-6698.
    doi: 10.1016/j.bmc.2013.08.014. Epub 2013 Aug 12.
  12. The search for new drugs synthesis and antiviral activity of derivatives of meristotropic and macedonic acids
    Zarubaev V.V., Kiselev O.I.,  Shtro A.A., Zorina A.D., Balykina L.V., Esipenko N.A., Anokhina V.V., Bukkreeva T.V.
    Pharmaceutical Chemistry Journal. – 2013. – Vol.46, № 10. – P.579-583.
    (Original version: Khim.-Pharm.Journ. – 2012. – Vol.46, № 10. – P.3-7.)
  13. Synthesis and biological activity of fullerenols with various contents of hydroxyl groups
    Eropkin M.Y., Bryazzhikova T.S., Eropkina E.M., Danilenko D.M., Kiselev O.I., Melenevskaya E.Y., Nasonova  K.V.
    Pharmaceutical Chemistry Journal. – 2013. – Vol.47, № 2. – P.87-91.
    (Original version: Khim.-Pharm.Journ. – 2013. – Vol.47, № 2. – P.19-23.)
  14. Phylogenetic analysis of six-domain multi-copper blue proteins
    Vasin A.V., Klotchenko S.A., Puchkova L.V.
    PLoS Curr. 2013 Mar 13;5.
  15. Current Methods of Human and Animal Brucellosis Diagnostics
    Smirnova E., Vasin A., Sandybaev N., Klotchenko S., Plotnikova M., Chervyakova O., Sansyzbay A., Kiselev O.
    Advances in Infectious Diseases. – 2013 – V. 3. – N. 3. – P.177-184
  16. A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles
    Blokhina E.A., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Kiselev O.I., Ravin N.V., Skryabin K.G.*
    Virology. – 2013. – Vol. 435, № 2. – P.293-300.
     doi: 10.16/j.virol.2012.09.014. Epub 2012 Oct 11.
  17. Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector
    Venanzi F., Shifrin V., Sherman M., Gabai V., Kiselev O.,  Komissarov A., Grudinin M., Shartukova M., Romanovskaya-Romanko E.A., Kudryavets Y., Bezdenezhnykh N., Lykhova O., Semesyuk N., Concetti A., Tsyb A., Filimonova M., Makarchuk V., Yakubovsky R., Chursov A., Shcherbinina V., Shneider A.*
    Oncotarget. – 2013. – Vol.4, № 10. – P.1829-1835.

Books and proceedings:

7th Vaccine & ISV ongress 2013, Barcelona, Spain, October 27–29, 2013:

  • Protective properties of inactivated virosomal influenza vaccine
    Erofeeva .., Nickonorov I.J., Maksakova V.L., Stukova M.A., Konshina O.S., Okhapkina E.A., Voicehovskaya E.M., Korovkin S.A., Melnikhov S.J., Kiselev O.I.
  • High specific activity of the vaccine preparation comprising recombinant protein with 4 copies of the influenza virus M2e
    Tsybalova L., Stepanova L., Kupriyanov V., Potapchuk M., Korotkov A., Ravin N.

5th European Congress of Virology, Lyon, France, September, 11–14 2013:

  • Multiplicity of infection determines cell fate in human monolayer cell cultures after influenza A virus infection
    Danilenko D.M., Smirnova T.D., Eropkin M. Yu.
  • Antiviral and cytoprotective activities of fullerenols with the different content of hydroxyl groups
    Eropkin M.Yu., Melenevskay E., Bryazhikova T., Eropkina E., Danilenko D.M.

Options for the control of influenza VIII, Cape Town, South Africa, September 5–10, 2013:

  • Potential Use of Rat Polyclonal Antisera for Antigenic Analysis of Human Influenza Viruses
    Danilenko D.M., Konovalova N.I., Eropkin M. Yu., Smith D.J., Russell C.A.
  • Drug resistance of influenza virus strains circulated in Russia during four epidemic seasons 2009-2010, 2010-2011, 2011-2012 and 2012-2013
    P.M. Anfimov, A.A. Sominina, V.V. Zarubaev, M.P. Grudinin, M.Y. Eropkin, O.I. Kiselev
  • Antiviral activity of usnic acid derivatives against influenza virus in vivo
    A.A. Shtro, O.A. Luzina, M.P. Polovinka, D. N. Sokolov, N. I. Komarova, N. F. Salakhutdinov, O. I. Kiselev, V.V. Zarubaev
  • Novel class of low molecular anti-influenza agents based on camphor pharmacophore
    Zarubaev V.V., Sokolova A.S., Yarovaya O.I., Shernyukov A.V., Tretiak T.S., Anfimov P.M., Kiselev O.I., Salakhutdinov N.F.
  • Molecular genetic characterization of influenza A and B virus strains circulated in Russia in 2010-2013
    Mikhail Grudinin, Anna Kosheleva, Andrey Komissarov, Artem Fadeev, Maria Pisareva, Janna Buzitskaya, Marina Stukova, Oleg Kiselev
  • Main factor of the low antigen content of inactivated H5N1 influenza vaccines – decreased stability of the H5 hemagglutinin protein
    Sergeeva M.V., Krokhin A.A., Tsybalova L.M., Romanova J.R.

“Mechanisms in Biology” 38th Federation of European Biochemical Societies Congress, St. Petersburg, Russia, 6–11 July, 2013:

  • Molecular mechanisms enhancing the coding potential of RNA genome of influenza A viruses
    Vasin A., Temkina O., Klotchenko S., Plotnikova M., Egorov V., Kiselev O.
  • Short peptides which enhance the fibrillogenesis of the model peptide
    Egorov V., Shaldzhyan A., Sirotkin A., Mirgorodskaya O., Vasin A., Lebedev D., Shvetsov A., Grudinina N., Shavlovsky M.
  • Development of multiplex real-time PCR for quantification of cytokines mRNA expression in influenza virus infected human cells
    Plotnikova M., Vasin A.
  • In silico analysis of the conserved regions with stable secondary structure within the NS gene of human influenza A viruses
    Klotchenko S., Brodskaya A., Temkina O., Vasin A.
  • Mechanisms of immunosuppression in viral infections: From retroviruses to Ebola and influenza viruses
    Kiselev O.
  • Thiol-disulfide system as universal biomarker for personalized therapy of infectious diseases and cancer
    Volchek I., Sologub T., Petrov A.

2012

Research papers:

  1. Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009
    Sokolov D. N., Zarubaev V. V., Shtro A. A., Polovinka M. P., Luzina O. A., Salakhutdinov N. F., Kiselev O. I.
    Bioorg Med Chem Lett. – 2012. – V. 22. – .7060-7064
  2. The European Virus Archive: A new source for virology research
    Gould E.A., de Lamballerie X., Goutard B., Eropkin M. et al.
    Antiviral Res. – 2012. – V.95. – N2. – P. 167-171.
  3. Controlled trypsinolysis of human cancer and non-cancer sera for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
    Toropygin I.Yu., Mirgorodskaya O.A., Moshkovskii S.A., Serebryakova M.V., Archakov A.I.
    International Journal of Mass Spectrometry. – 2012. – V.325-327. – P.121-129
  4. Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice
    Tarasov S.A., Zarubaev V.V., Gorbunov E.A., Sergeeva S.A, Epstein O.I.
    Antiviral Res. – 2012. – V.93. – N2. – P. 219-224
  5. Dynamic of Cell Population Structure in Liver Biopsy of the Patients with Chronic Hepatitis Viral Infection
    Tokin I.B., Filimonova G., Tokin I.I., Hussar P.
    Papers on Anthropology. – 2012. – V. XXI. – P. 276-286
  6. New recombinant strain A/HK/Astana/6:2/2010 for prophylaxis of A/H5N1 influenza
    Sultankova K.T., Sandybaev N.T., Chervyakova O.V., Strochkov V.M., Tailakova E.T., Sanayzbay A.R., rynbaev M.B., Gorev N.E., Sergeyeva M.V., Potapchuk M.V., Repko I.A., Tsybalova L.M., Kiselev O.I.
    Biotechnology Research Bulletin. – 2012. – V.1. – P.005-014

Books and proceedings:

  • Virology Textbook
    A.V. Pinevich, A.K. Sirotkin, O.V. Gavrilova, A.A. Potekhin
    St. Petersburg State University, 2012, 432 p.
  • Chronic Viral Hepatitis C: Diagnosis and Clinical Features
    O.P. Dudanova, O.I. Kiselev
    Petrozavodsk, 2012, 80 p.
  • Influenza: Epidemiology, Virology, Prevention and Treatment. Conference for Young Scientists. Collected Papers
    Edited by: L.M. Tsybalova, Dr.Med.Sci, V.V. Egorov, PhD
    St. Petersburg, 2012, 70 p.
  • Influenza: Epidemiology, Virology, Prevention and Treatment. 45th Anniversary Conference Proceedings
    Epub(pdf), 2012, 42 p.
  • Influenza: Epidemiology, Diagnosis, Prevention and Treatment
    Monograph. Edited by: O.I.Kiselev, L.M. Tsybalova, V.I. Pokrovsky
    Moscow, 2012, 496 p.
  • Avian Influenza. The Origin of Biological Disasters. 2nd edition
    edited by V.I. Pokrovsky et al.
    St. Petersburg, 2012, Rostok, 304 p.
  • Influenza and Pregnancy: Combination of Functional and Infectional Immunosuppression
    O.I.Kiselev, V.I. Pokrovsky
    St. Petersburg, 2012, 148 p.
  • Chemo Drugs and Influenza Chemotherapy
    O.I.Kiselev
    St. Petersburg, 2012, Rostok, 272 p.

2011

  1. Influenza: Epidemiology, Prevention and Treatment. Articles and Abstracts
    St. Petersburg, 2011, NP–Print, 72 p. 
  2. Genome of Pandemic Influenza A/H1N1–2009/10 Virus.
    O.I.Kiselev
    St. Petersburg–Moscow, 2011, Dimitrade Graphic Grougp, 164 p.
  3. Topical Problems of Socially Significant Viral Infections. Materials of the 10th Anniversary Russian–Italian Conference
    Edited by O.I.Kiselev, DrBiolSci., G.S. Arkhipov, DrMedSci., E.I. Arkhipova, DrMedSci.
    Velikiy Novgorod, 2011, ZAO «Novgorodskiy Technopark», 172 p.
  4. Guidelines for Virus Isolation, Influenza IFA and PCR Diagnosis and Submitting Sentinel Surveillance Data Online
    St. Petersburg, 2011, 68 p.
  5. Isolation, antigenic analysis and biological properties of pandemic influenza viruses A(H1N1)v circulated in Russian Federation in the epidemic season 2009-2010
    Eropkin M.U., Danilenko D.M., Konovalova N.I., Grigorieva V.A., Ivanova A.I., Gudkova T.M., Grigorieva V.A., Smirnova T.S.
    Turkish Journal of Clinical Laboratory. – 2011. – Vol. 2, № 1. – P. 27-33.
  6. Differential cell culture susceptibility and proliferative response to avian, human, and swine influenza viruses
    Danilenko D.M., Smirnova T.D., Gudkova T.M., Eropkin M.Yu., Kiselev O.I.
    Influenza and Other Respiratory Viruses. – 2011. - Vol. 5, Suppl. 1. – P. 54-59.
  7. Pandemic influenza in Russia: detection and molecular characterization of the H1N1v virus
    Grudinin M., Komissarov A., Pisareva M., Stukova M., Buzitskaya J., Elpaeva E., Slita A., Romanovskaya-Romanko E., Azarenok A., Prochukhanova A., Kiselev O.
    Influenza and Other Respiratory Viruses. – 2011. – Vol. 5, Suppl. 1. – P. 395-397.
  8. Pandemic influenza 2009 in Russia: isolation, antigenic analysis, and biological properties of viruses
    Eropkin M.Y., Danilenko D.M., Konovalova N.I., Ivanova A.V., Gudkova T.M., Grigorieva V.A.
    Influenza and Other Respiratory Viruses. – 2011. – Vol. 5, Suppl. 1. – P. 416-418.
  9. Comparison of influenza outbreaks in the Republic of Kazakhstan and Russia induced by 2009 yearly new variant of (H1N1) influenza virus
    Karpova L.S., Popovtseva N.M., Stolyarova T.P., Stolyarov K.A., Mamadaliyev S.M., Khairullin B.M., Sandybayev N.T., Kydyrbayev Zh.K., Orynbayev M.B., Ospanov K.S., Baiserkin B.S., Boibosinov E.U.
    Virologica Sinica. – 2011. – Vol.26, № 5. – P. 306-314.
  10. Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture
    Roethl E., Gassner M., Krenn B.M., Romanovskaya-Romanko E.A., Seper H., Romanova J., Nakowitsch S., Sturlan S., Wolschek M., Sirotkin A., Kiselev O., Muster T., Egorov A.
    Journal of Virology. – 2011. – Vol. 85, № 21. – P. 11139-11145.
  11. Modeling of self-organization of two-dimensional ordered structures
    Egorov V.V., Garmay Y.P., Shaldzhyan A.A., Lebedev D.V., Vasin A.V., Grudinina N.A., Kiselev O.I.
    Journal of Physics: Conference Series. – 2011. – Vol. 291, № 1, 012005. DOI: 10.1088/1742-6596/291/1/012005
  12. Multisegment one-step RT-PCR fluorescent labeling of influenza A virus genome for use in diagnostic microarray application
    Vasin A.V., Sandybaev N.T., Plotnikova M.A., Klotchenko S.A., Chervyakova O.V. Strochkov V.M., Taylakova E.T., Elpaeva E.A., Komissarov A.B., Egorov V.V., Koshemetov J.K., Kiselev O.I., Mamadaliev S.M.
    Journal of Physics: Conference Series. – 2011. – Vol. 291, № 1, 012006. DOI: 10.1088/1742-6596/291/1/012006
  13. Expression in E. coli and purification of the fibrillogenic fusion proteins TTR-sfGFP and β2M-sfGFP
    Solovyov K.V., Polyakov D.S., Grudinina N.A., Egorov V.V., Morozova I.V., Aleynikova T.D., Shavlovsky M.M.
    Preparative Biochemistry and Biotechnology. – 2011. – Vol. 41, № 4. – P.337-349.
  14. Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
    Krenn B.M., Egorov A., Romanovskaya-Romanko E., Wolschek M., Nakowitsch S., Ruthsatz T., Kiefmann B., Morokutti A., Humer J., Geiler J., Cinatl J., Wressnigg N., Sturlan S., Ferko B., Batishev O.V., Indenbom A.V., Zhu R ., Kastner M ., Hinterdorfer P., Kiselev O., Muster T., Romanova J.
    PLoS One. – 2011. – Vol. 6, № 4, e 18577. DOI: 10.1371/journal.pone.0018577
  15. Antiviral activity of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol and its derivatives against influenza A(H1N1)2009 virus
    Ardashov O.V., Zarubaev V.V., Shtro A.A., Korchagina D.V., Volcho K.P., Salakhutdinov N.F., Kiselev O.I.
    Letters in Drug Design & Discovery. – 2011. – Vol. 8, № 4. – p. 375-380.
  16. Dependence of biological effects of fullerene C60 in vitro from the type of preparations
    Piotrovsky L.B., Dumpis M.A., Litasova E.V., Eropkin M.Yu., Eropkina E.M., Kiselev O.I.
    Fullerenes, Nanotubes and Carbon Nanostructures. – 2011. – Vol. 19, № 1. – P. 147-153.
  17. Birch bark extract as therapy for chronic hepatitis C – A pilot study
    Shikov A. N., Djachuk G. I., Sergeev D. V., Pozharitskaya O. N., Esaulenko E. V., Kosman V. M., Makarov V. G.
    Phytomedicine. – 2011. – Vol.18, № 10. – P.807-810.

2010

  1. Influenza Pandemic 2009/2010: Antiviral Therapy and Treatment Schemes
    O.I. Kiselev ,F.I. Ershov, A.T. Bykov, V.I. Pokrovsky
    2010, A–Print, 100 p.
  2. «Antiviral properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B virus replication»
    Karpenko I., Deev S., Kiselev O., Charushin V., Rusinov V., Ulomsky E., Deeva E., Yanvarev D., Ivanov A., Smirnova O., Kochetkov S., Chupakhin O, .Kukhanova M.
    Antimicrobial Agents and Chemotherapy - 2010. –V. 54. # 5 – P. 2017-2022
  3. «Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus»
    Zarubaev V. V., Golod E. L., Anfimov P. M., Shtro A. A., Saraev V. V., Gavrilov A. S., Logvinov A. V., Kiselev O. I.
    Bioorg. Med. Chem. 2010, V. 18 – P.839-848.
  4. «Determination of total aminothiols and neuroactive aminoacids in plasma by high performance liquid chromatography with fluorescence detection»
    Pozdeev V. K., Pozdeyev N. V.
    Biochemistry (Moscow) supplement series B: Boimedical chemistry. -2010. – V. 4, № 3 - .288-295.
  5. «Mass spectrometry and biochemical analysis of RNA polymerase II: targeting by protein phosphatase-1»
    Jerebtsova M., Klotchenko S., Artamonova T., Ammosova T., Washington K., Egorov V., Shaldzhyan A., Sergeeva M., Zatulovskiy E., Temkina O., Petukhov M., Vasin A., Khodorkovskii M., Orlov Yu., Nekhai S.
    Mol Cell Biochem DOI 10.1007/s11010-010-0614-3 Published online: 13 October 2010.

2009

  1. «Development of a live-attenuated influenza B DelNS1 intranasal vaccine candidate»
    N. Wressnigg, D. Voss, T. Wolff, J. Romanova, T. Ruthsatz, I. Mayerhofer, M. Reiter, S. Nakowitsch, J. Humer, A. Morokutti, T. Muster, A. Egorov, C. Kittel
    Vaccine. – 2009. – Vol.27, № 21. – P.2851-2857
  2. «Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice»
    N. Wressnigg, A.-P. Shurygina, T. Wolff, M. Redlberger-Fritz, T. Popow-Kraupp, T. Muster, A. Egorov, C. Kittel
    J. Gen. Virology. –2009. Vol. 90, pt. 2. – P. 366-374